US20110097402A1 - Non-adhesive elastic gelatin matrices - Google Patents
Non-adhesive elastic gelatin matrices Download PDFInfo
- Publication number
- US20110097402A1 US20110097402A1 US11/664,184 US66418405A US2011097402A1 US 20110097402 A1 US20110097402 A1 US 20110097402A1 US 66418405 A US66418405 A US 66418405A US 2011097402 A1 US2011097402 A1 US 2011097402A1
- Authority
- US
- United States
- Prior art keywords
- matrix
- composition
- gelatin
- weight
- mixtures
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/225—Mixtures of macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
- A61L15/325—Collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/425—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/041—Mixtures of macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/043—Proteins; Polypeptides; Degradation products thereof
- A61L31/045—Gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/146—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/04—Alginic acid; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L89/00—Compositions of proteins; Compositions of derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L89/00—Compositions of proteins; Compositions of derivatives thereof
- C08L89/04—Products derived from waste materials, e.g. horn, hoof or hair
- C08L89/06—Products derived from waste materials, e.g. horn, hoof or hair derived from leather or skin, e.g. gelatin
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L2205/00—Polymer mixtures characterised by other features
- C08L2205/02—Polymer mixtures characterised by other features containing two or more polymers of the same C08L -group
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L71/00—Compositions of polyethers obtained by reactions forming an ether link in the main chain; Compositions of derivatives of such polymers
Definitions
- the present invention relates to non-adhesive elastic matrices. More specifically, the present invention relates to non-adhesive cross-linked elastic gelatin matrices, and the method of making the same.
- the matrices can be provided in a variety of configurations not limited to wound dressings, wound barriers, tissue and vascular coverings.
- the matrices can also be made to incorporate a variety of pharmaceuticals, chemicals and other agents.
- the non-adhesive elastic matrices of the present invention can be used alone, or in conjunction with other materials.
- Gelatin sheets, collagen sheets and sponges are a group of biomaterials that have been used extensively in the medical field. They are dry and absorb and retain large amounts of water. This group of biomaterials is both biocompatible and biodegradable causing little or no inflammation. These biomaterials are useful as wound dressings, artificial skin scaffolds and therapeutic drug delivery devices, whereby the biomaterials can retain therapeutics and deliver such therapeutics to appropriate cells and tissues, as exemplified in Applicant's U.S. Pat. No. 6,475,516.
- Gelatin and collagen sheets as provided by the prior art are typically inelastic and may have toxic properties.
- U.S. Pat. No. 3,491,760 describes a pliable, but inelastic, adhesive multilayer wound covering composed of collagen or gelatin which is “foamed” using air bubbles, treated with a plasticizer (glycerol), cross-linked with a 4% glutaraldehyde solution, and the resulting gel film covered with an adhered cover layer.
- a plasticizer glycol
- collagen and gelatin matrices cross-linked with glutaraldehyde show residual toxicity.
- Gelatin sponge materials such as GelfoamTM, are also known. These materials are absorbable, sterile and water insoluble and used to control bleeding during surgery and may also be provided in a powder format. The material is non-elastic. Another non-elastic gelatin sponge currently used is SurgifoamTM. GelfimTM is a non-elastic material obtained from a formaldehyde cross-linked gelatin solution.
- Hydrolyzed collagen also known as gelatin
- gelatin has been used as a vehicle for the delivery of therapeutics when covalently attached to the surface of tubular medical devices such as catheters and stents as described in Applicant's U.S. Pat. Nos. 6,132,765 and 6,228,393.
- the material is hydrated and minimally elastic.
- Sehal and Vijay describe a method for water-soluble carbodiimide-mediated amidation by using 1-ethyl-3-[3-dimethylaminopropyl carbodiimide (EDC)/N-hydroxy succinimide (NHS).
- EDC 1-ethyl-3-[3-dimethylaminopropyl carbodiimide
- NHS N-hydroxy succinimide
- the method is known to cross-link collagen, gelatin and other proteins.
- the resultant matrices are not elastic.
- soft elastic gelatin capsules or “Softgels” are made from a gelatin solution that is plasticized with propylene glycol, sorbitol, glycerin or other approved mixtures.
- the gelatin in the softgel capsules is not cross-linked in order that the capsules remain soluble when ingested.
- softgel capsules lack elasticity and resistance to the action of degradative processes such as increased temperature and mild enzymatic action.
- gelatin matrices that are elastic, and have appreciable tensile strength while not being prone to becoming hard and brittle.
- the present invention provides substantially non-adhesive, proteinaceous, elastic matrices for a variety of clinical uses. More specifically, the present invention provides substantially non-adhesive, elastic gelatin matrices for use in a variety of applications not limited to, wound barriers, wound dressings, surgical dressings, wraps and in therapeutic drug and/or chemical agent delivery. The present invention also provides a novel method for making the non-adhesive, elastic gelatin matrices of the invention.
- non-adhesive elastic gelatin matrix is both non-adhesive and elastic such that it is flexible.
- the matrix is lyophilized such that it does not contain substantial amounts of solvent and comprises a mixture of collagen or denatured collagen, biocompatible polymers, cross-linking agent(s) and optional plasticizer.
- a lyophilized non-adhesive elastic gelatin matrix is a lyophilized non-adhesive elastic gelatin matrix.
- non-adhesive elastic protein matrix comprising;
- collagen or denatured collagen i.e. gelatin is used alone as the protein component of the matrix.
- collagen and gelatin are used in combination as the protein component of the matrix.
- a non-adhesive elastic gelatin matrix comprising;
- the collagen can be used alone or denatured collagen, i.e. gelatin used alone or in combination.
- a method for making a non-adhesive elastic gelatin matrix comprising:
- the protein of (a) is gelatin and in other aspects is a mixture of gelatin and collagen.
- a plasticizer may additionally be added to (b) and/or (c).
- one or more of a pharmaceutical, chemical or other agent may be added before and/or after the cross-linking reaction of step (c).
- silver ions, metallic silver or a silver salt may be added to the matrix for the treatment of burns or other trauma to minimize and/or inhibit infection.
- the matrix may be fabricated as a covering such as wound barrier, wound dressing, vascular wrap and combinations thereof.
- the matrix may also be fabricated as a sponge.
- the matrix of the invention may be further used to reduce chronic inflammation, absorb exudates and/or promote a moist wound environment.
- the matrix of the invention may also have incorporated therein a chemical or other agent that is delivered to a desired tissue for at least one of exfoliation and treatment of age related conditions in mammals.
- the non-adhesive elastic gelatin matrix may be formed around a web or fibril support. Still in other aspects of the invention, the gelatin matrix of the invention may be used in conjunction with polymer sheets, films, threads or membranes and meshes of silicone, polyurethane, polyethylene, DacronTM, nylon, silk, cellulose and mixtures thereof.
- the non-adhesive elastic gelatin matrix may be provided as an occlusive device comprising an occlusive structure and the substantially non-adhesive gelatin matrix, wherein the matrix has opposing surfaces such that one surface of the matrix is affixed to one surface of the occlusive structure with the other surface of the matrix being adapted to cover and be in contact with tissue.
- the occlusive device may be a plastic film for example.
- the present invention is a novel substantially non-adhesive elastic protein containing matrix that is biocompatible.
- the matrix is an elastic gelatin matrix that retains its elasticity such that it can be configured in a variety of manners as is required in various clinical conditions.
- the elastic gelatin matrix of the invention is flexible and has a variety of clinical uses for the treatment of a variety of conditions.
- the matrix of the invention can be configured into a variety of formats and used in conjunction with other devices or structures.
- the matrix of the invention may also have a variety of pharmaceuticals, chemicals and/or other agents incorporated into the matrix as desired for a variety of clinical applications.
- the gelatin matrix of the invention is also substantially non-adhesive meaning that the matrix does not substantially adhere to wounds, tissues (such as but not limited to skin, blood vessels and bone) and organs.
- the matrix of the invention is absorbent, stable in vivo and in vitro and can be fabricated with a tensile strength and elasticity as required for a desired clinical application.
- the elastic matrix of the invention is made from a solution comprising protein or a mixture of proteins, biocompatible polymer(s), cross-linking agent(s), solvent(s) and optionally plasticizer(s).
- the protein for use in the invention is selected from collagen, denatured collagen (i.e. gelatin) and mixtures thereof that are further admixed together with one or more biocompatible polymers. Plasticizers may be optionally added.
- the solution is lyophilized to essentially remove any solvent and provide the non-adhesive elastic gelatin matrix of the invention.
- biocompatible polymers for use in the invention are selected from the group consisting of polyethylene glycol (PEG), poly-L-lysine, poly-D-lysine, alginate, chitosan, hyaluronic acid, chondroitin sulfate and mixtures thereof.
- the cross-linking agents for use in the invention are selected from the group consisting of 1-[3-(dimethylamino)propyl]-3-ethyl carbodiimide (EDC), N-hydroxysuccinimide (NHS), formaldehyde, glutaraldehyde, polyaziridines, diglycidyl ethers and mixtures thereof.
- EDC 1-[3-(dimethylamino)propyl]-3-ethyl carbodiimide
- NHS N-hydroxysuccinimide
- formaldehyde glutaraldehyde
- polyaziridines diglycidyl ethers and mixtures thereof.
- diglycidyl ethers diglycidyl ethers and mixtures thereof.
- EDC and NHS are used in combination as the cross-linking agent.
- the optional plasticizer for use in the present invention is selected from the group consisting of glycerol, propylene glycol, sorbitol and mixtures thereof.
- the solvent for use in the present invention is selected from the group consisting of water, methanol, ethanol, isopropanol, dimethylsulfide (DMS), and mixtures thereof.
- the solvent is water or if used in addition with a polar organic solvent, the solvent ratio is typically about 9:1, water to polar organic solvent, in the final mixture.
- the solution of collagen and/or gelatin together with the biocompatible polymer(s), cross-linking agent(s), optional plasticizer(s) and solvent(s) are mixed and frozen, and then freeze-dried (i.e. lyophilized).
- the matrices so produced are substantially non-adhesive and elastic.
- the ranges for the amounts of protein (collagen or gelatin), the amount of biocompatible polymer, the amount of solvent and the amount of optional plasticizer in the composition solution and in the lyophilized final composition may be as follows:
- Plasticizer optionally 0-5% 0-10% *Note that the ranges provided in the table above for each of the protein, biocompatible polymer, cross-linking agent, solvent and plasticizer includes any sub ranges of the ranges listed.
- the non-adhesive elastic gelatin matrix of the invention is made by combining solutions of protein, biocompatible polymers and cross-linking agents in a suitable solvent.
- the solutions of the various constituents of the matrix as described in the examples are aqueous, however, in aspects of the invention the biocompatible polymer(s) and cross-linking agent(s) may be first dissolved in a polar organic solvent such as but not limited to methanol, ethanol, isopropanol and dimethyl sulfoxide (DMSO), and in such a case, the solvent ratio of the final mixture is typically 9:1 in favor of water.
- a polar organic solvent such as but not limited to methanol, ethanol, isopropanol and dimethyl sulfoxide (DMSO)
- solutions of the protein and biocompatible polymer are mixed and incubated for a time period at a temperature such that the protein does not set, i.e. form a gel. Temperatures of about 55° C. are suitable for such incubation. Should polyethylene glycol (PEG) be used as a biocompatible polymer, the PEG is typically added to the mixing and incubating protein solutions. A solution of cross-linking agent is then added and the resultant mixture is mixed for a period of time until a consistent gel is formed. The gel is then pored into a suitable mold and kept at room temperature for about 10 minutes and subsequently cooled at about 4° C. for a time period ranging from about 30 minutes up to about 12 hours.
- PEG polyethylene glycol
- the mixture is washed to remove soluble components such as residual PEG and cross-linking agent and lyophilized for a period of about 24 hours or more until the final moisture content of the non-adhesive elastic gelatin matrix is less than about 10%. It is understood by one of skill in the art that the final moisture content of the resultant matrix (lyophilized matrix) can be adjusted to any value up to about 10% by weight of the matrix.
- the non-adhesive elastic gelatin matrix of the invention can be developed to be drug-eluting on tissues and organs, including but not limited to, skin, tissue lacerations, surgical wounds of skin, tissue and organs, blood vessels and bone.
- the matrix can be fabricated to have pharmaceutical, chemical and/or other agent incorporated therein.
- the pharmaceutical, chemical and/or other agent can be incorporated in an amount of about 0.1% to about 10% into the initial formulation step or about 1.0% to about 25% after drying.
- the lyophilized matrix can be soaked in a solution of the desired pharmaceutical, chemical and/or other agent and then the matrix may be re-lyophilized.
- Desirable agents for use in conjunction with the present invention include but are not limited to silver ions, metallic silver or a silver salt, chlorohexidine, triclosan, povidone-Iodine, other antimicrobial metals such as copper, platinum, gold, bismuth-based compounds, anesthetics such as lidocaine, antibiotics, immunosuppressants, antiproliferative agents, anti-inflammatory agents, antivirals and combinations thereof.
- an anti-ageing agent may be provided to the matrix before and/or after lyophilization.
- Such an anti-aging agent may be selected to treat for example fine lines, wrinkles and skin discolorations.
- a suitable anti-aging agent may be selected from exfoliants, Vitamin A, Vitamin C, etc. If used to treat brown spots or discoloration an agent such as hydroquinone may be suitable for incorporation into the matrix.
- the non-adhesive elastic gelatin matrix of the invention can be fabricated in a variety of forms such as a film, sheet, tube or sponge.
- the matrix of the invention may be used for example but not limited to a wound barrier, wound dressing, vascular wrap and combinations thereof.
- the matrix of the invention may also be used to reduce chronic inflammation, absorb exudates and/or promote a moist wound environment.
- the matrix of the invention can also be fabricated as a device in conjunction with other materials such as but not limited to polymer sheets, films, threads, membranes or meshes of silicone, polyurethane, polyethylene, DacronTM, nylon, silk, cellulose and combinations thereof.
- This may be carried out by chemically modifying the surface of the other material by methods of gamma irradiation, plasma or corona discharge and/or by UV light so that reactive groups are introduced onto the surface of the material.
- the reactive groups can then be covalently linked to complementary reactive groups present on the non-adhesive elastic matrix of the present invention by methods as described in the Applicant's International Application No. PCT CA02/00246 (the disclosure of which is incorporated herein by reference in its entirety).
- Gelatin was purchased from Vyse Gelatin Company (5010 North Rose St., Schiller Park, Ill. 60176). Gelatin (300 Bloom) was obtained by the partial hydrolysis of a collagen derived from porcine sources: skin, white connective tissues and bones of animals and processed to yield a pharmaceutical grade gelatin. Sodium alginate (sodium salt) from Macrocystis pyrifera (high viscosity, 2% solution at 25° C. approx 14,000 cps) was purchased from Sigma Co. (St. Louis, Mo.).
- Gelatin (100 mL) and alginate (71.2 mL) solutions were mixed and Incubated at 55° C. for 30 min. Then 30 mL of PEG 3400 solution was added and mixed. Afterward, 5 mL of fresh EDC/NHS solution was added to the mixture during mixing for 30 seconds. The about 200 ml of gel was poured into a mold and kept at room temperature for 10 min and subsequently cooled at 4° C. for 30 min. The matrix was washed in water overnight to remove soluble components such as PEG and cross-linking agent. Finally, the matrix was lyophilized. Typically, 0.32 ml of gel mixture yields 1 cm 2 of matrix surface area.
- Gelatin (100 mL) and alginate (71.2 mL) solutions were mixed and incubated at 55° C. for 30 min. Then 30 mL of PEG 3400 solution was added and mixed. Afterward, 5 mL of fresh EDC/NHS solution was added to the mixture during mixing for 30 seconds.
- the about 200 ml of gel was poured into a mold and kept at room temperature for 10 min and subsequently cooled at 4° C. for 30 min. The matrix was washed in water overnight to remove soluble components such as PEG and cross-linking agent. Usually, 0.32 ml of gel mixture yields 1 cm 2 of matrix surface area. The matrix was soaked in 2.85 L of 10% glycerol (4.4 ml of glycerol per 1 cm 2 of gel). Finally the matrix was lyophilized.
- Gelatin and alginate solutions were mixed as in previous examples. Then 10 ml of 2% poly-L-lysine was added with mixing. 30 ml of PEG 3400 was added to the mixture and mixed. The remaining procedures to yield the final matrix were identical to previous examples.
- Gelatin and alginate solutions were mixed as in previous examples. Then 10 ml of 2% poly-L-lysine was added with mixing. 30 ml of PEG 3400 was added to the mixture and mixed. The remaining procedures to yield the hydrated and washed matrix were identical to previous examples. Finally, the matrix was soaked in 2.85 L of 10% glycerol (4.4 ml of glycerol per 1 cm 2 of gel) and then lyophilized.
- Matrix Synthesis (e.g. 200 ml of Gel)
- the various matrices as in Examples 1-5 can be poured (prior to the initial cooling/freezing step) directly over other materials (without modification as outlined above), such as but not limited to polymer sheets, films, threads, membranes or meshes of silicone, polyurethane, polyethylene, DacronTM, nylon, silk, cellulose and combinations thereof. that may or may not contain added agents, such as therapeutics, silver-containing materials or other medicaments so as to embed the mesh, net or fibers within the matrices of examples 1-5.
- materials such as but not limited to polymer sheets, films, threads, membranes or meshes of silicone, polyurethane, polyethylene, DacronTM, nylon, silk, cellulose and combinations thereof. that may or may not contain added agents, such as therapeutics, silver-containing materials or other medicaments so as to embed the mesh, net or fibers within the matrices of examples 1-5.
- the degradation of cross-linked gelatin-based materials was studied using bacterial collagenase.
- the collagenase used in this study was from Clostridium (EC 3.4.24.3) and had an activity of 362 U/mg solid.
- the water uptake ability of the dressing was expressed as the weight ratio of absorbed water to dry dressing (Table 2). Matrices particularly without plasticiser are all very absorbent and can soak up to approximately 30-35 times their weight in water in about 24 hours.
- Examples 1-5 are directed to the manufacture of a range materials that may be used as carriers for various medicaments such as the antiproliferative and anti-inflammatory drug Sirolimus (Rapamycin) for delivery to the surface of tissues and organs. While the drug Sirolimus is used in this example, it is noted that other drugs may be used either alone or in combination to be delivered to the surface of tissues and organs.
- Sirolimus the antiproliferative and anti-inflammatory drug Sirolimus
- Solution 1 2 g of gelatin was added to 180 ml of water; after gelatin was completely hydrated in water, the mixture was incubated at 50° C. to dissolve the gelatin.
- Solution 2 0.2 g of alginate was added into 20 ml of 0.05 N NaOH, and incubated at 50° C. to dissolve the alginate.
- Solution 4 2 g of glycerol was added into 200 ml of water
- Matrix Synthesis (e.g. 200 ml of Gel)
- the above matrix (or any of the matrices of examples 1-5) was cut into 1 ⁇ 4 cm square. Afterwards, 80 ul of drug solution (1 mg/80 ul ethanol) was added on the surface of the material, or the material was immersed in a solution of drug. After drug loading into the film, the film was allowed to dry and the drug-loaded film was exposed to gamma-irradiation for 8 hr (25 KGy).
- Injection volume 10 ⁇ l Sirolimus Standards 0 ug/ml, 1 ug/ml, 2.5 ug/ml, 5 ug/ml 10 ug/ml Analysis: Each sample was injected two times for analysis. Each data point is the average of 6 replicate tests.
Abstract
The present invention is a substantially non-adhesive elastic gelatin matrix. The matrix is both non-adhesive to wounds, tissues and organs and is also elastic such that it is flexible. The matrix is a lyophilized mixture of protein(s), polymer(s), cross-linking agent(s) and optional plasticizer(s). The invention also provides methods for making the non-adhesive elastic gelatin matrix.
Description
- The present invention relates to non-adhesive elastic matrices. More specifically, the present invention relates to non-adhesive cross-linked elastic gelatin matrices, and the method of making the same. The matrices can be provided in a variety of configurations not limited to wound dressings, wound barriers, tissue and vascular coverings. The matrices can also be made to incorporate a variety of pharmaceuticals, chemicals and other agents. Further, the non-adhesive elastic matrices of the present invention can be used alone, or in conjunction with other materials.
- Gelatin sheets, collagen sheets and sponges are a group of biomaterials that have been used extensively in the medical field. They are dry and absorb and retain large amounts of water. This group of biomaterials is both biocompatible and biodegradable causing little or no inflammation. These biomaterials are useful as wound dressings, artificial skin scaffolds and therapeutic drug delivery devices, whereby the biomaterials can retain therapeutics and deliver such therapeutics to appropriate cells and tissues, as exemplified in Applicant's U.S. Pat. No. 6,475,516.
- Gelatin and collagen sheets as provided by the prior art are typically inelastic and may have toxic properties. For example, U.S. Pat. No. 3,491,760 describes a pliable, but inelastic, adhesive multilayer wound covering composed of collagen or gelatin which is “foamed” using air bubbles, treated with a plasticizer (glycerol), cross-linked with a 4% glutaraldehyde solution, and the resulting gel film covered with an adhered cover layer. As is generally known collagen and gelatin matrices cross-linked with glutaraldehyde show residual toxicity.
- Gelatin sponge materials such as Gelfoam™, are also known. These materials are absorbable, sterile and water insoluble and used to control bleeding during surgery and may also be provided in a powder format. The material is non-elastic. Another non-elastic gelatin sponge currently used is Surgifoam™. Gelfim™ is a non-elastic material obtained from a formaldehyde cross-linked gelatin solution.
- Hydrolyzed collagen, also known as gelatin, has been used as a vehicle for the delivery of therapeutics when covalently attached to the surface of tubular medical devices such as catheters and stents as described in Applicant's U.S. Pat. Nos. 6,132,765 and 6,228,393. The material is hydrated and minimally elastic.
- Several patents describe cross-linked inelastic collagen materials such as for example U.S. Pat. Nos. 4,703,108, 4,970,298, 5,550,187, 5,744,545, and 6,132,765.
- Sehal and Vijay (Anal. Biochem. 218: 87-91, 1994) describe a method for water-soluble carbodiimide-mediated amidation by using 1-ethyl-3-[3-dimethylaminopropyl carbodiimide (EDC)/N-hydroxy succinimide (NHS). The method is known to cross-link collagen, gelatin and other proteins. However, the resultant matrices are not elastic.
- Choi et al. (Biomaterials 20: 409-41, 1999) describe the fabrication of a gelatin-containing artificial skin that contains gelatin and alginate and is cross-linked with EDC. A soluble sponge was immersed in a solution of acetone:water (9:1 by volume) containing 20-100 mg EDC and cross-linked for 24 hr. The EDC when dissolved in water is stated to be deactivated and rapidly loses its cross-linking ability and thus the EDC was dissolved in 90% acetone. The matrix material produced is inherently inelastic.
- In the pharmaceutical industry, soft elastic gelatin capsules or “Softgels” are made from a gelatin solution that is plasticized with propylene glycol, sorbitol, glycerin or other approved mixtures. However, the gelatin in the softgel capsules is not cross-linked in order that the capsules remain soluble when ingested. Furthermore, softgel capsules lack elasticity and resistance to the action of degradative processes such as increased temperature and mild enzymatic action.
- There is a need to produce gelatin matrices that are elastic, and have appreciable tensile strength while not being prone to becoming hard and brittle.
- The present invention provides substantially non-adhesive, proteinaceous, elastic matrices for a variety of clinical uses. More specifically, the present invention provides substantially non-adhesive, elastic gelatin matrices for use in a variety of applications not limited to, wound barriers, wound dressings, surgical dressings, wraps and in therapeutic drug and/or chemical agent delivery. The present invention also provides a novel method for making the non-adhesive, elastic gelatin matrices of the invention.
- In accordance with an aspect of the present invention is a non-adhesive elastic gelatin matrix. The matrix is both non-adhesive and elastic such that it is flexible. The matrix is lyophilized such that it does not contain substantial amounts of solvent and comprises a mixture of collagen or denatured collagen, biocompatible polymers, cross-linking agent(s) and optional plasticizer.
- In accordance with another aspect of the present invention is a lyophilized non-adhesive elastic gelatin matrix.
- In accordance with another aspect of the present invention is a non-adhesive elastic protein matrix, the matrix comprising;
-
- a mixture of protein comprising collagen and/or gelatin, biocompatible polymers, one or more cross-linking agents. In aspects, the mixture may further comprise one or more plasticizers. In other aspects, the mixture is lyophilized.
- In aspects, collagen or denatured collagen, i.e. gelatin is used alone as the protein component of the matrix. In alternative aspects, collagen and gelatin are used in combination as the protein component of the matrix.
- In accordance with another aspect of the present invention is a non-adhesive elastic gelatin matrix, the matrix comprising;
-
- a mixture of protein comprising collagen and/or gelatin and biocompatible polymers comprising alginate, polyethylene glycol and poly-L-lysine, wherein said polymers are cross-linked with one or more cross-linking agents and said mixture is lyophilized. In aspects, the mixture may further comprise one or more plasticizers.
- In aspects, the collagen can be used alone or denatured collagen, i.e. gelatin used alone or in combination.
- In accordance with another aspect of the present invention, there is provided a method for making a non-adhesive elastic gelatin matrix, the method comprising:
-
- lyophilizing a frozen solution comprising at least one protein, at least one biocompatible polymer and at least one cross-linking agent for a time effective to substantially remove the solvent. In aspects, the solution also comprises a plasticizer.
- In accordance with still another aspect of the present invention is a method for making a non-adhesive elastic gelatin matrix, the method comprising:
-
- (a) heating a protein solution;
- (b) adding one or more biocompatible polymers to (a);
- (c) adding at least one cross-linking agent to (b);
- (d) cooling (c) and lyophilizing.
- In aspects of the invention, the protein of (a) is gelatin and in other aspects is a mixture of gelatin and collagen. A plasticizer may additionally be added to (b) and/or (c). Furthermore, one or more of a pharmaceutical, chemical or other agent may be added before and/or after the cross-linking reaction of step (c). For example, silver ions, metallic silver or a silver salt may be added to the matrix for the treatment of burns or other trauma to minimize and/or inhibit infection. The matrix may be fabricated as a covering such as wound barrier, wound dressing, vascular wrap and combinations thereof. The matrix may also be fabricated as a sponge. The matrix of the invention may be further used to reduce chronic inflammation, absorb exudates and/or promote a moist wound environment. The matrix of the invention may also have incorporated therein a chemical or other agent that is delivered to a desired tissue for at least one of exfoliation and treatment of age related conditions in mammals.
- In aspects of the invention, the non-adhesive elastic gelatin matrix may be formed around a web or fibril support. Still in other aspects of the invention, the gelatin matrix of the invention may be used in conjunction with polymer sheets, films, threads or membranes and meshes of silicone, polyurethane, polyethylene, Dacron™, nylon, silk, cellulose and mixtures thereof.
- In other aspects of the present invention, the non-adhesive elastic gelatin matrix may be provided as an occlusive device comprising an occlusive structure and the substantially non-adhesive gelatin matrix, wherein the matrix has opposing surfaces such that one surface of the matrix is affixed to one surface of the occlusive structure with the other surface of the matrix being adapted to cover and be in contact with tissue. In such aspects the occlusive device may be a plastic film for example.
- Other features and advantages of the present invention will become apparent from the following detailed description. It should be understood, however, that the detailed description and the specific examples while indicating embodiments of the invention are given by way of illustration only, since various changes and modifications within the spirit and scope of the invention will become apparent to those skilled in the art from the detailed description.
- The present invention is a novel substantially non-adhesive elastic protein containing matrix that is biocompatible. In embodiments of the invention, the matrix is an elastic gelatin matrix that retains its elasticity such that it can be configured in a variety of manners as is required in various clinical conditions. As such the elastic gelatin matrix of the invention is flexible and has a variety of clinical uses for the treatment of a variety of conditions. Furthermore, the matrix of the invention can be configured into a variety of formats and used in conjunction with other devices or structures. The matrix of the invention may also have a variety of pharmaceuticals, chemicals and/or other agents incorporated into the matrix as desired for a variety of clinical applications. The gelatin matrix of the invention is also substantially non-adhesive meaning that the matrix does not substantially adhere to wounds, tissues (such as but not limited to skin, blood vessels and bone) and organs. Lastly, the matrix of the invention is absorbent, stable in vivo and in vitro and can be fabricated with a tensile strength and elasticity as required for a desired clinical application.
- The elastic matrix of the invention is made from a solution comprising protein or a mixture of proteins, biocompatible polymer(s), cross-linking agent(s), solvent(s) and optionally plasticizer(s). The protein for use in the invention is selected from collagen, denatured collagen (i.e. gelatin) and mixtures thereof that are further admixed together with one or more biocompatible polymers. Plasticizers may be optionally added. The solution is lyophilized to essentially remove any solvent and provide the non-adhesive elastic gelatin matrix of the invention.
- In aspects of the invention the biocompatible polymers for use in the invention are selected from the group consisting of polyethylene glycol (PEG), poly-L-lysine, poly-D-lysine, alginate, chitosan, hyaluronic acid, chondroitin sulfate and mixtures thereof.
- In aspects of the invention the cross-linking agents for use in the invention are selected from the group consisting of 1-[3-(dimethylamino)propyl]-3-ethyl carbodiimide (EDC), N-hydroxysuccinimide (NHS), formaldehyde, glutaraldehyde, polyaziridines, diglycidyl ethers and mixtures thereof. In embodiments, EDC and NHS are used in combination as the cross-linking agent.
- In aspects of the invention the optional plasticizer for use in the present invention is selected from the group consisting of glycerol, propylene glycol, sorbitol and mixtures thereof.
- In aspects of the invention the solvent for use in the present invention is selected from the group consisting of water, methanol, ethanol, isopropanol, dimethylsulfide (DMS), and mixtures thereof. In aspects of the invention the solvent is water or if used in addition with a polar organic solvent, the solvent ratio is typically about 9:1, water to polar organic solvent, in the final mixture.
- The solution of collagen and/or gelatin together with the biocompatible polymer(s), cross-linking agent(s), optional plasticizer(s) and solvent(s) are mixed and frozen, and then freeze-dried (i.e. lyophilized). The matrices so produced are substantially non-adhesive and elastic.
- The ranges for the amounts of protein (collagen or gelatin), the amount of biocompatible polymer, the amount of solvent and the amount of optional plasticizer in the composition solution and in the lyophilized final composition may be as follows:
-
% by weight in lyophilized non- % by weight adhesive elastic in initial gelatin matrix, composition lyophilized Protein- 0.5-30% 50-90% collagen or denatured collagen (i.e. gelatin) Biocompatible polymer up to about 10% up to about 40% (in aspects about 10-40%) Cross-linking agent 0.1-2% 0.5-5% Solvent 50-99% up to about 10% Plasticizer (optional) 0-5% 0-10% *Note that the ranges provided in the table above for each of the protein, biocompatible polymer, cross-linking agent, solvent and plasticizer includes any sub ranges of the ranges listed. - The non-adhesive elastic gelatin matrix of the invention is made by combining solutions of protein, biocompatible polymers and cross-linking agents in a suitable solvent. The solutions of the various constituents of the matrix as described in the examples are aqueous, however, in aspects of the invention the biocompatible polymer(s) and cross-linking agent(s) may be first dissolved in a polar organic solvent such as but not limited to methanol, ethanol, isopropanol and dimethyl sulfoxide (DMSO), and in such a case, the solvent ratio of the final mixture is typically 9:1 in favor of water.
- In aspects of the invention, solutions of the protein and biocompatible polymer are mixed and incubated for a time period at a temperature such that the protein does not set, i.e. form a gel. Temperatures of about 55° C. are suitable for such incubation. Should polyethylene glycol (PEG) be used as a biocompatible polymer, the PEG is typically added to the mixing and incubating protein solutions. A solution of cross-linking agent is then added and the resultant mixture is mixed for a period of time until a consistent gel is formed. The gel is then pored into a suitable mold and kept at room temperature for about 10 minutes and subsequently cooled at about 4° C. for a time period ranging from about 30 minutes up to about 12 hours. The mixture is washed to remove soluble components such as residual PEG and cross-linking agent and lyophilized for a period of about 24 hours or more until the final moisture content of the non-adhesive elastic gelatin matrix is less than about 10%. It is understood by one of skill in the art that the final moisture content of the resultant matrix (lyophilized matrix) can be adjusted to any value up to about 10% by weight of the matrix.
- The non-adhesive elastic gelatin matrix of the invention can be developed to be drug-eluting on tissues and organs, including but not limited to, skin, tissue lacerations, surgical wounds of skin, tissue and organs, blood vessels and bone. In this embodiment, the matrix can be fabricated to have pharmaceutical, chemical and/or other agent incorporated therein. In one aspect, the pharmaceutical, chemical and/or other agent can be incorporated in an amount of about 0.1% to about 10% into the initial formulation step or about 1.0% to about 25% after drying. In another aspect the lyophilized matrix can be soaked in a solution of the desired pharmaceutical, chemical and/or other agent and then the matrix may be re-lyophilized. Desirable agents for use in conjunction with the present invention include but are not limited to silver ions, metallic silver or a silver salt, chlorohexidine, triclosan, povidone-Iodine, other antimicrobial metals such as copper, platinum, gold, bismuth-based compounds, anesthetics such as lidocaine, antibiotics, immunosuppressants, antiproliferative agents, anti-inflammatory agents, antivirals and combinations thereof. The selection of the agent for use with the matrix of the invention will depend on its end use. For example, if used for the treatment of age-related conditions, an anti-ageing agent may be provided to the matrix before and/or after lyophilization. Such an anti-aging agent may be selected to treat for example fine lines, wrinkles and skin discolorations. In this aspect a suitable anti-aging agent may be selected from exfoliants, Vitamin A, Vitamin C, etc. If used to treat brown spots or discoloration an agent such as hydroquinone may be suitable for incorporation into the matrix.
- The non-adhesive elastic gelatin matrix of the invention can be fabricated in a variety of forms such as a film, sheet, tube or sponge. The matrix of the invention may be used for example but not limited to a wound barrier, wound dressing, vascular wrap and combinations thereof. The matrix of the invention may also be used to reduce chronic inflammation, absorb exudates and/or promote a moist wound environment. The matrix of the invention can also be fabricated as a device in conjunction with other materials such as but not limited to polymer sheets, films, threads, membranes or meshes of silicone, polyurethane, polyethylene, Dacron™, nylon, silk, cellulose and combinations thereof. This may be carried out by chemically modifying the surface of the other material by methods of gamma irradiation, plasma or corona discharge and/or by UV light so that reactive groups are introduced onto the surface of the material. The reactive groups can then be covalently linked to complementary reactive groups present on the non-adhesive elastic matrix of the present invention by methods as described in the Applicant's International Application No. PCT CA02/00246 (the disclosure of which is incorporated herein by reference in its entirety).
- The above disclosure generally describes the present invention. A more complete understanding can be obtained by reference to the following specific Examples. These Examples are described solely for purposes of illustration and are not intended to limit the scope of the invention. Changes in form and substitution of equivalents are contemplated as circumstances may suggest or render expedient. Although specific terms have been employed herein, such terms are intended in a descriptive sense and not for purposes of limitation.
- Without intending to be limiting in scope, the following examples serve to illustrate various embodiments of the invention.
- Gelatin was purchased from Vyse Gelatin Company (5010 North Rose St., Schiller Park, Ill. 60176). Gelatin (300 Bloom) was obtained by the partial hydrolysis of a collagen derived from porcine sources: skin, white connective tissues and bones of animals and processed to yield a pharmaceutical grade gelatin. Sodium alginate (sodium salt) from Macrocystis pyrifera (high viscosity, 2% solution at 25° C. approx 14,000 cps) was purchased from Sigma Co. (St. Louis, Mo.). Polyethyleneglycol (Average Mn=3,400), 1-[3-(dimethylamino)propyl]-3-ethylcarbodiimide hydrochloride (EDC) and N-hydroxysuccinimide (NHS) and silver lactate were purchased from Aldrich Co. (Milwaukee, Wis. 53201).
-
-
Stock solutions: Gelatin: 20% (w/v) Alginate: 3.12% (w/v) PEG 3400: 63% (w/v) EDC/NHS: 40% (w/v) and 6% (w/v), respectively, (molar ratio: 4/1) Composition of water-saturated matrix: Gelatin: 10% (w/w) Alginate: 1.1% (w/w) PEG: 7.2% (w/w) - Gelatin (100 mL) and alginate (71.2 mL) solutions were mixed and Incubated at 55° C. for 30 min. Then 30 mL of PEG 3400 solution was added and mixed. Afterward, 5 mL of fresh EDC/NHS solution was added to the mixture during mixing for 30 seconds. The about 200 ml of gel was poured into a mold and kept at room temperature for 10 min and subsequently cooled at 4° C. for 30 min. The matrix was washed in water overnight to remove soluble components such as PEG and cross-linking agent. Finally, the matrix was lyophilized. Typically, 0.32 ml of gel mixture yields 1 cm2 of matrix surface area.
-
-
Stock solution: Gelatin: 20% (w/v) Alginate: 3.12% (w/v) PEG 3400: 63% (w/v) EDC/NHS: 40% (w/v) and 6% (w/v), respectively, (molar ratio: 4/1) Glycerol: 10% (w/v) Composition of water-saturated matrix: Gelatin: 10% (w/w) Alginate: 1.1% (w/w) PEG: 7.2% (w/w) Poly-Lysine: 0.1% (w/w)
Matrix Synthesis (e.g. 200 ml of gel) - Gelatin (100 mL) and alginate (71.2 mL) solutions were mixed and incubated at 55° C. for 30 min. Then 30 mL of PEG 3400 solution was added and mixed. Afterward, 5 mL of fresh EDC/NHS solution was added to the mixture during mixing for 30 seconds. The about 200 ml of gel was poured into a mold and kept at room temperature for 10 min and subsequently cooled at 4° C. for 30 min. The matrix was washed in water overnight to remove soluble components such as PEG and cross-linking agent. Usually, 0.32 ml of gel mixture yields 1 cm2 of matrix surface area. The matrix was soaked in 2.85 L of 10% glycerol (4.4 ml of glycerol per 1 cm2 of gel). Finally the matrix was lyophilized.
-
-
Stock solution: Gelatin: 20% (w/v) Alginate: 3.12% (w/v) PEG 3400: 63% (w/v) Poly-L- 2% (w/v) Lysine: EDC/NHS: 40% (w/v) and 6% (w/v), respectively, (molar ratio: 4/1) Composition of water-saturated matrix: Gelatin: 10% (w/w) Alginate: 1.1% (w/w) PEG: 7.2% (w/w) Poly-lysine: 0.1% (w/w) - Gelatin and alginate solutions were mixed as in previous examples. Then 10 ml of 2% poly-L-lysine was added with mixing. 30 ml of PEG 3400 was added to the mixture and mixed. The remaining procedures to yield the final matrix were identical to previous examples.
-
-
Stock solution: Gelatin: 20% (w/v) Alginate: 3.12% (w/v) PEG 3400: 63% (w/v) Poly-L- 2% (w/v) Lysine: EDC/NHS: 40% (w/v) and 6% (w/v), respectively, (molar ratio: 4/1) Glycerol: 10% (w/v) Composition of water-saturated matrix: Gelatin: 10% (w/w) Alginate: 1.1% (w/w) PEG: 7.2% (w/w) Poly-L- 0.1% (w/w) lysine: - Gelatin and alginate solutions were mixed as in previous examples. Then 10 ml of 2% poly-L-lysine was added with mixing. 30 ml of PEG 3400 was added to the mixture and mixed. The remaining procedures to yield the hydrated and washed matrix were identical to previous examples. Finally, the matrix was soaked in 2.85 L of 10% glycerol (4.4 ml of glycerol per 1 cm2 of gel) and then lyophilized.
-
-
Stock solution: Gelatin: 1% (w/v) Alginate: 1% (w/v) EDC/NHS: 40% (w/v) and 6% (w/v), respectively, (molar ratio: 4/1) Composition of water-saturated matrix: Gelatin: 0.9% (w/w) Alginate: 0.1% (w/w) - Gelatin (180 mL) and alginate (20 mL) solutions were mixed and incubated at 55° C. for 30 min. Afterward 1.4 ml of fresh EDC/NHS solution was added to the mixture with mixing for 1 minute. The mixture was poured into a mold (10 ml per 20 cm2 area), and then frozen at −20° C. overnight. Finally, the matrix was lyophilized.
- The various matrices as in Examples 1-5 can be poured (prior to the initial cooling/freezing step) directly over other materials (without modification as outlined above), such as but not limited to polymer sheets, films, threads, membranes or meshes of silicone, polyurethane, polyethylene, Dacron™, nylon, silk, cellulose and combinations thereof. that may or may not contain added agents, such as therapeutics, silver-containing materials or other medicaments so as to embed the mesh, net or fibers within the matrices of examples 1-5.
- The degradation of cross-linked gelatin-based materials was studied using bacterial collagenase. The collagenase used in this study was from Clostridium (EC 3.4.24.3) and had an activity of 362 U/mg solid. Samples (50 mg) were incubated at 37° C. in 10 mL of collagenase solution with concentration of 15.35 U/mg in 0.1 M Tris-HCl buffer (pH=7.4) containing 0.005 M CaCl2 and 0.05 mg/mL sodium azide. After each incubation interval, the sample was carefully washed three times with de-ionized water and lyophilized overnight. The extent of degradation was expressed as the percentage of weight remaining after degradation.
- The biodegradation of gelatin-based dressings in accordance with the present invention was rapid in the presence of collagenase, as would be expected. For nearly all of the matrices, approximately 80% of the gelatin sponge was degraded in the first 24 hours. The gelatin matrix containing gelatin and aliginate appeared less affected by the action of collagenase (Table 1).
-
TABLE 1 Biodegradation of gelatin dressings at specified times (expressed as % of weight remaining) in the presence of collagenase. Sample Matrix 0 hr 24 hr 48 hr 72 hr 1% Gelatin + Alginate 100 96.1 75.9 65.4 10% Gelatin + PEG + Alginate 100 21.0 22.2 17.4 10% Gelatin + PEG + Alginate + 100 23.3 12.8 21.8 Glycerol 10% Gelatin + PEG + Alginate + 100 18.4 14.3 14.4 Glycerol + Poly-L- Lysine 10% Gelatin + PEG + Alginate + 100 16.5 14.8 12.6 Poly-L-Lysine - To determine the water uptake ability of the dressing, about 40 mg of dressing was placed in a 20 ml glass vial to which was added 15 ml of water or PBS (0.01M, pH=7.4). The sample was weighed after hydration for 5 min at room temperature and then incubated at 37° C. for 4 hr and 24 hr. The sample was weighed at both incubation intervals. The water uptake ability is expressed as the weight ratio of absorbed water to dry dressing (Table 2). Matrices particularly without plasticiser are all very absorbent and can soak up to approximately 30-35 times their weight in water in about 24 hours.
-
TABLE 2 Water uptake at specified times, grams of water/grams of matrix (g/g) 5 min 4 hr 24 hr Sample Matrix (g/g) (g/g) (g/g) 1% Gelatin + Alginate 31.6 — 28.7 10% Gelatin + PEG + Alginate 16.2 27.3 32.1 10% Gelatin + PEG + 2.5 10.8 11.7 Alginate + Glycerol 10% Gelatin + PEG + 9.0 29.9 34.6 Alginate + Poly-L- Lysine 10% Gelatin + PEG + Alginate + 1.8 9.6 10.5 Poly-L-Lysine + Glycerol *values are a ratio, value: 1. - To determine the water solubility of the dressing, place a sample with a known weight was placed into a glass vial to which 15 mls of water was added. This was incubated at 40° C. for 24 hr and then the water removed and the sample washed twice with water. The sample was then dried in a 100° C. oven to a constant weight and then re-weighed. The water solubility is typically expressed as percentage of weight lost after water treatment (Table 3). The matrices exhibited a good water solubility providing an indication of its clinical longevity. Lower solubility resulted in a more stable matrix at body temperature. Thus such matrices can be removed from a would for example as a single sheet after 24 hours or more with minimum patient discomfort. While all matrices demonstrated good stability, those without plasticizer were even more stable.
-
TABLE 3 Stability of 10% gelatin-based materials after incubation in 40° C. water for 24 hr. Weight Water Remain- Solu- W1 W2 ing bility Sample Matrix (g) (g) (%) (%) 1% Gelatin + Alginate 0.0315 0.0260 83.4 16.6 10% Gelatin + PEG + Alginate 0.0335 0.0261 77.9 22.1 10% Gelatin + PEG + Alginate 0.0308 0.0235 76.3 23.7 10% Gelatin + PEG + 0.0448 0.0107 23.9 76.1 Alginate + Glycerol 10% Gelatin + PEG + 0.0443 0.0108 24.4 75.6 Alginate + Glycerol 10% Gelatin + PEG + 0.0364 0.0305 83.8 16.2 Alginate + Poly-L- Lysine 10% Gelatin + PEG + 0.0361 0.0294 81.4 18.6 Alginate + Poly-L- Lysine 10% Gelatin + PEG + 0.0504 0.0115 22.82 77.2 Alginate + Poly-L-Lysine + Glycerol 10% gelatin + PEG + Alginate + 0.0507 0.0124 24.5 75.5 Poly-L-Lysine + Glycerol Note: W1: weight of original sample W2: weight of dried sample after treatment Weight Remaining = (W2/W1) × 100% Water solubility = (1 − W2/W1) × 100% - The mechanical properties were determined for the tensile strength and elongation at break of hydrated gelatin matrices (4.5 cm×1 cm), which had been soaked in 0.01M, pH=7.4 PBS buffer solution for 1 hour at room temperature. A 0.5 kg load cell was used with an extension rate of 5 mm/min (Table 4). This example demonstrates that tensile strength and elasticity of the matrices can be adjusted through the variation of the amount and combination of components of the matrix. This is valuable for providing matrices for a variety of clinical applications such as an artificial skin or wound dressing.
-
TABLE 4 Mechanical properties of gelatin-based dressings. Tensile Elongation Strength at Break Sample No. (g/cm2) (%) 1% Gelatin + Alginate 25.5 53.0 10% gelatin + PEG 30.5 126.8 10% Gelatin + PEG + Alginate 73.8 174.9 10% Gelatin + PEG + Alginate + 83.8 155.4 glycerol 10% Gelatin + PEG + Alginate + 111.4 176.3 Poly-L- Lysine 10% Gelatin + PEG + Alginate + 148.8 193.3 Poly-L-Lysine + glycerol - Examples 1-5 are directed to the manufacture of a range materials that may be used as carriers for various medicaments such as the antiproliferative and anti-inflammatory drug Sirolimus (Rapamycin) for delivery to the surface of tissues and organs. While the drug Sirolimus is used in this example, it is noted that other drugs may be used either alone or in combination to be delivered to the surface of tissues and organs.
-
Stock solution: Gelatin: 1% to water Alginate: 1% to 0.05 N NaOH EDC/NHS: 400 mg/60 mg per 1 ml of 10 mM of Mes saline solution (pH = 4.5) Glycerol: 1% (in water). The formulation in the matrix: Gelatin: 0.9% (w/v) Alginate: 0.1% (w/v) Water - Solution 1: 2 g of gelatin was added to 180 ml of water; after gelatin was completely hydrated in water, the mixture was incubated at 50° C. to dissolve the gelatin.
Solution 2: 0.2 g of alginate was added into 20 ml of 0.05 N NaOH, and incubated at 50° C. to dissolve the alginate.
Solution 3: 400 mg of EDC+60 mg of NHS was added into 1 ml of 10 mM Mes saline solution (pH=4.5).
Solution 4: 2 g of glycerol was added into 200 ml of water -
-
- 1.
Solution 1 andSolution 2 were mixed and Incubated at 55° C. for 30 min. Afterward, 1.379 ml of fresh EDC/NHS solution was added to mixture with mixing for 1 minute. The mixture was poured into a mold (9 ml per 20 cm2 a, then froze at −20 degrees ° C. for overnight. - 2. Cross-linked gel was washed by Milli-
Q water 4 times with 500 ml per matrix (Refresh water every 1 hr); the matrix was refrozen at room temperature, soaked in 9 ml of 1% glycerol per 20 cm2 gel. Then gel was frozen again at −20° C. and lyophilized. The matrix may be prepared as a thin film.
- 1.
- The above matrix, (or any of the matrices of examples 1-5) was cut into 1×4 cm square. Afterwards, 80 ul of drug solution (1 mg/80 ul ethanol) was added on the surface of the material, or the material was immersed in a solution of drug. After drug loading into the film, the film was allowed to dry and the drug-loaded film was exposed to gamma-irradiation for 8 hr (25 KGy).
- 1) One matrix (1×4 cm) was cut into equal 3 pieces.
2) Dissolve 1 mg of drug In 90 ul of ethanol.
3) Adding 30 ul of drug solution into each matrix piece ofstep 1. - 1) Place samples in 15 ml of Falcon tubes.
2) Add 5 ml of PBS (10 mM, pH=7) to each tube.
3) Incubate tubes at 37° C. for 10 days.
4) Withdraw samples of 2.5 ml at Intervals of 3 hr, 1 day, 3 days, 5 days, 7 day, 9 days, and 2.5 ml fresh PBS was replaced for samples taken.
5) HPLC analysis of samples. - Flow rate: 0.2 ml/min
- Detection: UV, 278 nm
- Mobile phase: 600 ml acetonitrile and 400 ml of water
- Injection volume: 10 μl
Sirolimus Standards 0 ug/ml, 1 ug/ml, 2.5 ug/ml, 5 ug/ml 10 ug/ml
Analysis: Each sample was injected two times for analysis.
Each data point is the average of 6 replicate tests. - Although preferred embodiments of the Invention have been described herein in detail, it will be understood by those skilled in the art that variations may be made thereto without departing from the spirit of the invention or the scope of the appended claims.
Claims (63)
1. A non-adhesive elastic protein matrix comprising:
(a) one or more proteins;
(b) one or more biocompatible polymers; and
(c) one or more cross-linking agents,
wherein said matrix is lyophilized after addition of (c) to result in a matrix that does not substantially adhere to wounds, tissues and organs.
2. The matrix of claim 1 , wherein said matrix additionally comprises one or more plasticizers.
3. The matrix of claim 1 , wherein said protein is selected from the group consisting of collagen, denatured collagen and mixtures thereof.
4. The matrix of claim 1 , wherein said biocompatible polymer is selected from the group consisting of polyethylene glycol, poly-L-lysine, alginate, chitosan, hyaluronic acid, chondroitin sulfate and mixtures thereof.
5. The matrix of claim 1 , wherein said cross-linking agent is selected from the group consisting of 1-[3-(dimethylamino)propyl]-3-ethyl carbodiimide (EDC), N-hydroxysuccinimide (NHS), formaldehyde, glutaraldehyde, polyaziridines, diglycidyl ethers and mixtures thereof.
6. The matrix of claim 5 , wherein said cross-linking agent is a mixture of 1-[3-(dimethylamino)propyl]-3-ethyl carbodiimide (EDC) and N-hydroxysuccinimide (NHS).
7. The matrix of claim 1 , wherein said matrix contains less than about 10% moisture content.
8. The matrix of claim 1 , wherein said protein is provided in an amount of about 50% to about 90% by weight of said matrix.
9. The matrix of claim 1 , wherein said biocompatible polymer is provided in an amount of up to about 40% by weight of said matrix.
10. The matrix of claim 1 , wherein said cross-linking agent is provided in an amount of about 0.5% to about 5% by weight of said matrix.
11. The matrix of claim 2 , wherein said plasticizer is provided in an amount of up to about 10% by weight of said matrix.
12. The matrix of claim 1 , wherein said matrix additionally comprises one or more pharmaceutical, chemical and other agent.
13. The matrix of claim 12 , wherein said one or more pharmaceutical chemical and other agent is selected from the group consisting of antibiotic, antiviral, chlorhexidine, triclosan, povidone-iodine, antimicrobial metals, bismuth-based compounds, immunosuppressants, anti-proliferative agents, anti-inflammatory agents, anesthetics, anti-aging agents and mixtures thereof.
14. The matrix of claim 13 , wherein said antimicrobial metal is selected from the group consisting of silver ions, metallic silver, silver salt, copper, platinum, gold and mixtures thereof.
15. The matrix of claim 13 , wherein said anesthetic is lidocaine.
16. The matrix of claim 12 , wherein said one or more pharmaceutical, chemical and other agent is provided in an amount of about 1% to about 25% by weight of said matrix.
17. The matrix of claim 1 , wherein said matrix is provided as a film, sheet, tube or sponge.
18. The matrix of claim 1 , wherein said matrix is provided together with a material selected from the group consisting of polymer sheets, polymer films, threads, silicone membranes, silicone meshes, polyurethane, polyethylene, polyethylene terephthalate, nylon, silk, cellulose and combinations thereof.
19. The matrix of claim 1 , wherein said matrix is provided as a wound dressing, wound barrier, tissue cover or vascular cover.
20. The matrix of claim 13 , wherein said matrix is to reduce chronic inflammation.
21. The matrix of claim 1 , wherein said matrix is configured to absorb exudates.
22. The matrix of claim 1 , wherein said matrix is configured to promote a moist environment.
23. The matrix of claim 12 , wherein said pharmaceutical is sirolimus.
24. An elastic protein matrix composition comprising a mixture of:
(a) collagen, gelatin, or mixtures thereof;
(b) solvent;
(c) one or more biocompatible polymers;
(d) one or more cross-linking agents; and
(e) optionally one or more plasticizers,
wherein said composition is lyophilized after addition of (d) to result in a matrix that does not substantially adhere to wounds, tissues and organs.
25. The composition of claim 24 , wherein said collagen, gelatin, or mixtures thereof is provided in an amount of about 0.5% to about 30% by weight.
26. The composition of claim 24 , wherein said biocompatible polymer is provided in an amount of up to about 10% by weight.
27. The composition of claim 24 , wherein said cross-linking agent is provided in an amount of about 0.1% to about 2% by weight.
28. The composition of claim 24 , wherein said solvent is provided in an amount of about 50% to about 99% by weight.
29. The composition of claim 24 , wherein said plasticizer is provided in an amount of about 0 to about 5% by weight.
30. (canceled)
31. The composition of claim 24 , wherein said composition additionally comprises one or more pharmaceutical, chemical and other agent.
32. The composition of claim 31 , wherein said one or more pharmaceutical, chemical and other agent is selected from the group consisting of antibiotic, antiviral, chlorhexidine, immunosuppressants, anti-proliferative agents, anti-inflammatory agents, triclosan, povidone-iodine, antimicrobial metals, bismuth-based compounds, anesthetics, anti-aging agents and mixtures thereof.
33. The composition of claim 32 , wherein said antimicrobial metal is selected from the group consisting of silver ions, metallic silver, silver salt, copper, platinum, gold and mixtures thereof.
34. The composition of claim 33 , wherein said anesthetic is lidocaine.
35. The composition of claim 31 , wherein said pharmaceutical is sirolimus.
36. The composition of claim 31 , wherein said one or more pharmaceutical, chemical and other agent is provided in an amount of about 0.1% to about 10% by weight of said composition.
37. A method for making a non-adhesive elastic protein matrix, the method comprising:
lyophilizing a frozen solution comprising at least one protein, at least one biocompatible polymer and at least one cross-linking agent for a time effective to substantially remove the solvent to form said matrix wherein said matrix does not substantially adhere to wounds, tissues and organs.
38. A method for making a non-adhesive elastic gelatin matrix, the method comprising:
(a) heating a protein solution comprising collagen and/or gelatin;
(b) adding one or more biocompatible polymers to (a);
(c) adding at least one cross-linking agent to (b);
(d) cooling (c) and lyophilizing,
to form said matrix wherein said matrix does not substantially adhere to wounds, tissues and organs.
39. The method of claim 38 , wherein one or more plasticizers is added to (b), to (c), or to both (b) and (c).
40. The method of claim 38 , wherein one or more pharmaceutical, chemical or other agent may be added before step (c), after step (c), or before step (c) and after step (c).
41. The method of claim 38 , wherein said one or more pharmaceutical, chemical and other agent is selected from the group consisting of antibiotic, antiviral, chlorhexidine, triclosan, povidone-iodine, antimicrobial metals, anti-inflammatory agents, anti-proliferative agents, bismuth-based compounds, immunosuppressants, anesthetics, anti-aging agents and mixtures thereof.
42. The method of claim 41 , wherein said antimicrobial metal is selected from the group consisting of silver ions, metallic silver, silver salt, copper, platinum, gold and mixtures thereof.
43. The method of claim 41 , wherein said anesthetic is lidocaine.
44. The method of claim 40 , wherein said pharmaceutical is sirolimus.
45. The method of claim 40 , wherein said one or more pharmaceutical, chemical and other agent is provided in an amount of about 0.1% to about 10% by weight of said matrix.
46. An elastic protein matrix composition comprising the non-adhesive elastic protein matrix of claim 1 , a solvent, and optionally one or more plasticizers, wherein the one or more proteins is selected from the group consisting of collagen, gelatin and mixtures thereof.
47. The composition of claim 46 , wherein said biocompatible polymer is selected from the group consisting of polyethylene glycol, poly-L-lysine, alginate, chitosan, hyaluronic acid, chondroitin sulfate and mixtures thereof.
48. The composition of claim 46 , wherein said cross-linking agent is selected from the group consisting of 1[3-(dimethylamino)propyl]-3-ethyl carbodiimide (EDC), N-hydroxysuccinimide (NHS), formaldehyde, glutaraldehyde, polyaziridines, diglycidyl ethers and mixtures thereof.
49. The composition of claim 48 , wherein said cross-linking agent is a mixture of 1-[3-(dimethylamino)propyl]-3-ethyl carbodiimide (EDC) and N-hydroxysuccinimide (NHS).
50. The composition of claim 46 , wherein said collagen, gelatin or mixtures thereof is provided in an amount of about 0.5% to about 30% by weight.
51. The composition of claim 46 , wherein said biocompatible polymer is provided in an amount of up to about 10% by weight.
52. The composition of claim 46 , wherein said cross-linking agent is provided in an amount of about 0.1% to about 2% by weight.
53. The composition of claim 46 , wherein said solvent is provided in an amount of about 50% to about 99% by weight.
54. The composition of claim 46 , wherein said plasticizer is provided in an amount of about 0 to about 5% by weight.
55. The composition of claim 46 , wherein said composition is lyophilized to remove the solvent and have a moisture content of up to about 10% by weight.
56. The composition of claim 46 , wherein said composition additionally comprises one or more pharmaceutical, chemical and other agent.
57. The composition of claim 56 , wherein said one or more pharmaceutical, chemical and other agent is selected from the group consisting of antibiotic, antiviral, chlorhexidine, triclosan, povidone-iodine, antimicrobial metals, bismuth-based compounds, immunosuppressants, anti-proliferative agents, anti-inflammatory agents, anesthetics, anti-aging agents and mixtures thereof.
58. The composition of claim 57 , wherein said antimicrobial metal is selected from the group consisting of silver ions, metallic silver, silver salt, copper, platinum, gold and mixtures thereof.
59. The composition of claim 57 , wherein said anesthetic is lidocaine.
60. The composition of claim 56 wherein said pharmaceutical is sirolimus.
61. The composition of claim 56 , wherein said one or more pharmaceutical, chemical and other agent is provided in an amount of about 1% to about 25% by weight of said composition.
62. A method for making the non-adhesive elastic protein matrix of claim 1 , the method comprising:
lyophilizing a frozen solution of the matrix in a solvent for a time effective to substantially remove the solvent.
63. A method for making the non-adhesive elastic protein matrix of claim 3 , the method comprising:
(a) heating a protein solution comprising the collagen, gelatin or mixtures thereof;
(b) adding the one or more biocompatible polymers to (a);
(c) adding the one or more cross-linking agents to (b);
(d) cooling (c) and lyophilizing.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/664,184 US20110097402A1 (en) | 2004-09-30 | 2005-06-15 | Non-adhesive elastic gelatin matrices |
US13/166,433 US8354123B2 (en) | 2004-09-30 | 2011-06-22 | Non-adhesive elastic gelatin matrices |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US61441404P | 2004-09-30 | 2004-09-30 | |
PCT/CA2005/000925 WO2006034568A1 (en) | 2004-09-30 | 2005-06-15 | Non-adhesive elastic gelatin matrices |
US11/664,184 US20110097402A1 (en) | 2004-09-30 | 2005-06-15 | Non-adhesive elastic gelatin matrices |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CA2005/000925 A-371-Of-International WO2006034568A1 (en) | 2004-09-30 | 2005-06-15 | Non-adhesive elastic gelatin matrices |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/166,433 Continuation US8354123B2 (en) | 2004-09-30 | 2011-06-22 | Non-adhesive elastic gelatin matrices |
Publications (1)
Publication Number | Publication Date |
---|---|
US20110097402A1 true US20110097402A1 (en) | 2011-04-28 |
Family
ID=36118529
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/152,367 Active 2027-05-18 US8361501B2 (en) | 2004-09-30 | 2005-06-15 | Non-adhesive elastic gelatin matrices |
US11/664,184 Abandoned US20110097402A1 (en) | 2004-09-30 | 2005-06-15 | Non-adhesive elastic gelatin matrices |
US13/166,433 Active US8354123B2 (en) | 2004-09-30 | 2011-06-22 | Non-adhesive elastic gelatin matrices |
US13/750,872 Active US8628800B2 (en) | 2004-09-30 | 2013-01-25 | Non-adhesive elastic gelatin matrices |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/152,367 Active 2027-05-18 US8361501B2 (en) | 2004-09-30 | 2005-06-15 | Non-adhesive elastic gelatin matrices |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/166,433 Active US8354123B2 (en) | 2004-09-30 | 2011-06-22 | Non-adhesive elastic gelatin matrices |
US13/750,872 Active US8628800B2 (en) | 2004-09-30 | 2013-01-25 | Non-adhesive elastic gelatin matrices |
Country Status (11)
Country | Link |
---|---|
US (4) | US8361501B2 (en) |
EP (1) | EP1793872B1 (en) |
JP (1) | JP5047797B2 (en) |
AU (1) | AU2005289311B2 (en) |
CA (1) | CA2580357C (en) |
DK (1) | DK1793872T3 (en) |
EA (2) | EA016776B9 (en) |
ES (1) | ES2581558T3 (en) |
NO (1) | NO20071668L (en) |
UA (1) | UA88321C2 (en) |
WO (1) | WO2006034568A1 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090022801A1 (en) * | 2006-01-31 | 2009-01-22 | David Vachon | Compositions and Methods for Promoting the Healing of Tissue of Multicellular Organisms |
US20100247544A1 (en) * | 2006-01-31 | 2010-09-30 | Dr. David John Vachon | Compositions and Methods for Promoting the Healing of Tissue of Multicellular Organisms |
EP3088010A1 (en) | 2015-04-28 | 2016-11-02 | DiCosmo, Frank | Bioactive collagen biomaterials and methods for making |
US9970303B2 (en) | 2014-05-13 | 2018-05-15 | Entrotech, Inc. | Erosion protection sleeve |
CN110075346A (en) * | 2019-04-30 | 2019-08-02 | 苏州卫生职业技术学院 | A kind of high-adhesiveness aerogel dressing and preparation method thereof |
Families Citing this family (510)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7923431B2 (en) | 2001-12-21 | 2011-04-12 | Ferrosan Medical Devices A/S | Haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostatis |
JP2006509502A (en) * | 2002-12-11 | 2006-03-23 | フェローサン アクティーゼルスカブ | Gelatin-based material as a swab |
US9060770B2 (en) | 2003-05-20 | 2015-06-23 | Ethicon Endo-Surgery, Inc. | Robotically-driven surgical instrument with E-beam driver |
US20070084897A1 (en) | 2003-05-20 | 2007-04-19 | Shelton Frederick E Iv | Articulating surgical stapling instrument incorporating a two-piece e-beam firing mechanism |
JP2007519450A (en) * | 2004-01-30 | 2007-07-19 | フェロサン アー/エス | Hemostasis sprays and compositions |
AU2005262070B2 (en) * | 2004-07-09 | 2011-01-27 | Ferrosan Medical Devices A/S | Haemostatic composition comprising hyaluronic acid |
US11896225B2 (en) | 2004-07-28 | 2024-02-13 | Cilag Gmbh International | Staple cartridge comprising a pan |
US8215531B2 (en) | 2004-07-28 | 2012-07-10 | Ethicon Endo-Surgery, Inc. | Surgical stapling instrument having a medical substance dispenser |
JP5047797B2 (en) | 2004-09-30 | 2012-10-10 | コヴァロン・テクノロジーズ・インコーポレーテッド | Non-adhesive elastic gelatin matrix |
US10159482B2 (en) | 2005-08-31 | 2018-12-25 | Ethicon Llc | Fastener cartridge assembly comprising a fixed anvil and different staple heights |
US7934630B2 (en) | 2005-08-31 | 2011-05-03 | Ethicon Endo-Surgery, Inc. | Staple cartridges for forming staples having differing formed staple heights |
US11246590B2 (en) | 2005-08-31 | 2022-02-15 | Cilag Gmbh International | Staple cartridge including staple drivers having different unfired heights |
US20070194082A1 (en) | 2005-08-31 | 2007-08-23 | Morgan Jerome R | Surgical stapling device with anvil having staple forming pockets of varying depths |
US7669746B2 (en) | 2005-08-31 | 2010-03-02 | Ethicon Endo-Surgery, Inc. | Staple cartridges for forming staples having differing formed staple heights |
US9237891B2 (en) | 2005-08-31 | 2016-01-19 | Ethicon Endo-Surgery, Inc. | Robotically-controlled surgical stapling devices that produce formed staples having different lengths |
US11484312B2 (en) | 2005-08-31 | 2022-11-01 | Cilag Gmbh International | Staple cartridge comprising a staple driver arrangement |
US20070106317A1 (en) | 2005-11-09 | 2007-05-10 | Shelton Frederick E Iv | Hydraulically and electrically actuated articulation joints for surgical instruments |
US8820603B2 (en) | 2006-01-31 | 2014-09-02 | Ethicon Endo-Surgery, Inc. | Accessing data stored in a memory of a surgical instrument |
US8708213B2 (en) | 2006-01-31 | 2014-04-29 | Ethicon Endo-Surgery, Inc. | Surgical instrument having a feedback system |
US20110290856A1 (en) | 2006-01-31 | 2011-12-01 | Ethicon Endo-Surgery, Inc. | Robotically-controlled surgical instrument with force-feedback capabilities |
US9861359B2 (en) | 2006-01-31 | 2018-01-09 | Ethicon Llc | Powered surgical instruments with firing system lockout arrangements |
US11224427B2 (en) | 2006-01-31 | 2022-01-18 | Cilag Gmbh International | Surgical stapling system including a console and retraction assembly |
US7845537B2 (en) | 2006-01-31 | 2010-12-07 | Ethicon Endo-Surgery, Inc. | Surgical instrument having recording capabilities |
US11278279B2 (en) | 2006-01-31 | 2022-03-22 | Cilag Gmbh International | Surgical instrument assembly |
US8186555B2 (en) | 2006-01-31 | 2012-05-29 | Ethicon Endo-Surgery, Inc. | Motor-driven surgical cutting and fastening instrument with mechanical closure system |
US20110024477A1 (en) | 2009-02-06 | 2011-02-03 | Hall Steven G | Driven Surgical Stapler Improvements |
US20120292367A1 (en) | 2006-01-31 | 2012-11-22 | Ethicon Endo-Surgery, Inc. | Robotically-controlled end effector |
US7753904B2 (en) | 2006-01-31 | 2010-07-13 | Ethicon Endo-Surgery, Inc. | Endoscopic surgical instrument with a handle that can articulate with respect to the shaft |
US11793518B2 (en) | 2006-01-31 | 2023-10-24 | Cilag Gmbh International | Powered surgical instruments with firing system lockout arrangements |
US20110006101A1 (en) | 2009-02-06 | 2011-01-13 | EthiconEndo-Surgery, Inc. | Motor driven surgical fastener device with cutting member lockout arrangements |
US8992422B2 (en) | 2006-03-23 | 2015-03-31 | Ethicon Endo-Surgery, Inc. | Robotically-controlled endoscopic accessory channel |
US20070225562A1 (en) | 2006-03-23 | 2007-09-27 | Ethicon Endo-Surgery, Inc. | Articulating endoscopic accessory channel |
US8322455B2 (en) | 2006-06-27 | 2012-12-04 | Ethicon Endo-Surgery, Inc. | Manually driven surgical cutting and fastening instrument |
DE102006038252A1 (en) * | 2006-08-16 | 2008-02-21 | Lohmann & Rauscher Gmbh & Co. Kg | Preparation with marine collagen for proteinase inhibition |
US10130359B2 (en) | 2006-09-29 | 2018-11-20 | Ethicon Llc | Method for forming a staple |
US10568652B2 (en) | 2006-09-29 | 2020-02-25 | Ethicon Llc | Surgical staples having attached drivers of different heights and stapling instruments for deploying the same |
US8485412B2 (en) | 2006-09-29 | 2013-07-16 | Ethicon Endo-Surgery, Inc. | Surgical staples having attached drivers and stapling instruments for deploying the same |
KR20090096704A (en) | 2006-12-22 | 2009-09-14 | 큐나노 에이비 | Led with upstanding nanowire structure and method of producing such |
US8684253B2 (en) | 2007-01-10 | 2014-04-01 | Ethicon Endo-Surgery, Inc. | Surgical instrument with wireless communication between a control unit of a robotic system and remote sensor |
US11291441B2 (en) | 2007-01-10 | 2022-04-05 | Cilag Gmbh International | Surgical instrument with wireless communication between control unit and remote sensor |
US8652120B2 (en) | 2007-01-10 | 2014-02-18 | Ethicon Endo-Surgery, Inc. | Surgical instrument with wireless communication between control unit and sensor transponders |
US8701958B2 (en) | 2007-01-11 | 2014-04-22 | Ethicon Endo-Surgery, Inc. | Curved end effector for a surgical stapling device |
US11039836B2 (en) | 2007-01-11 | 2021-06-22 | Cilag Gmbh International | Staple cartridge for use with a surgical stapling instrument |
US8349589B2 (en) * | 2007-02-12 | 2013-01-08 | Fujifilm Manufacturing Europe B.V. | Non-natural recombinant gelatins with enhanced functionality |
EP1961414A1 (en) * | 2007-02-21 | 2008-08-27 | FUJIFILM Manufacturing Europe B.V. | A controlled release composition comprising a recombinant gelatin |
EP1961411A1 (en) * | 2007-02-21 | 2008-08-27 | FUJIFILM Manufacturing Europe B.V. | A controlled release composition |
US8727197B2 (en) | 2007-03-15 | 2014-05-20 | Ethicon Endo-Surgery, Inc. | Staple cartridge cavity configuration with cooperative surgical staple |
USRE47826E1 (en) | 2007-03-28 | 2020-01-28 | Innocoll Pharmaceuticals Limited | Drug delivery device for providing local analgesia, local anesthesia or nerve blockage |
JP5372905B2 (en) * | 2007-03-28 | 2013-12-18 | イノコル テクノロジーズ リミティッド | Drug delivery device for providing local analgesia, local anesthesia or nerve block |
US8893946B2 (en) | 2007-03-28 | 2014-11-25 | Ethicon Endo-Surgery, Inc. | Laparoscopic tissue thickness and clamp load measuring devices |
WO2008151040A2 (en) * | 2007-05-31 | 2008-12-11 | Cook Biotech Incorporated | Analgesic coated medical product |
US11672531B2 (en) | 2007-06-04 | 2023-06-13 | Cilag Gmbh International | Rotary drive systems for surgical instruments |
US8931682B2 (en) | 2007-06-04 | 2015-01-13 | Ethicon Endo-Surgery, Inc. | Robotically-controlled shaft based rotary drive systems for surgical instruments |
US8308040B2 (en) | 2007-06-22 | 2012-11-13 | Ethicon Endo-Surgery, Inc. | Surgical stapling instrument with an articulatable end effector |
US7753245B2 (en) | 2007-06-22 | 2010-07-13 | Ethicon Endo-Surgery, Inc. | Surgical stapling instruments |
US11849941B2 (en) | 2007-06-29 | 2023-12-26 | Cilag Gmbh International | Staple cartridge having staple cavities extending at a transverse angle relative to a longitudinal cartridge axis |
US20090004253A1 (en) | 2007-06-29 | 2009-01-01 | Brown Laura J | Composite device for the repair or regeneration of tissue |
DE102007044648B4 (en) * | 2007-09-18 | 2020-11-26 | Carl Freudenberg Kg | Bioresorbable gelatin non-woven fabric |
US20100298329A1 (en) * | 2007-09-19 | 2010-11-25 | Massachusette Institute Of Technology | Tolperisone and tolperisone-like drugs for the treatment of k-ras associated cancers |
US8679176B2 (en) | 2007-12-18 | 2014-03-25 | Cormatrix Cardiovascular, Inc | Prosthetic tissue valve |
US8257434B2 (en) | 2007-12-18 | 2012-09-04 | Cormatrix Cardiovascular, Inc. | Prosthetic tissue valve |
US7905381B2 (en) | 2008-09-19 | 2011-03-15 | Ethicon Endo-Surgery, Inc. | Surgical stapling instrument with cutting member arrangement |
US8561870B2 (en) | 2008-02-13 | 2013-10-22 | Ethicon Endo-Surgery, Inc. | Surgical stapling instrument |
US8657174B2 (en) | 2008-02-14 | 2014-02-25 | Ethicon Endo-Surgery, Inc. | Motorized surgical cutting and fastening instrument having handle based power source |
US9179912B2 (en) | 2008-02-14 | 2015-11-10 | Ethicon Endo-Surgery, Inc. | Robotically-controlled motorized surgical cutting and fastening instrument |
US7819298B2 (en) | 2008-02-14 | 2010-10-26 | Ethicon Endo-Surgery, Inc. | Surgical stapling apparatus with control features operable with one hand |
US7866527B2 (en) | 2008-02-14 | 2011-01-11 | Ethicon Endo-Surgery, Inc. | Surgical stapling apparatus with interlockable firing system |
US8636736B2 (en) | 2008-02-14 | 2014-01-28 | Ethicon Endo-Surgery, Inc. | Motorized surgical cutting and fastening instrument |
BRPI0901282A2 (en) | 2008-02-14 | 2009-11-17 | Ethicon Endo Surgery Inc | surgical cutting and fixation instrument with rf electrodes |
US8758391B2 (en) | 2008-02-14 | 2014-06-24 | Ethicon Endo-Surgery, Inc. | Interchangeable tools for surgical instruments |
US8573465B2 (en) | 2008-02-14 | 2013-11-05 | Ethicon Endo-Surgery, Inc. | Robotically-controlled surgical end effector system with rotary actuated closure systems |
US11272927B2 (en) | 2008-02-15 | 2022-03-15 | Cilag Gmbh International | Layer arrangements for surgical staple cartridges |
US9615826B2 (en) | 2010-09-30 | 2017-04-11 | Ethicon Endo-Surgery, Llc | Multiple thickness implantable layers for surgical stapling devices |
CA2716872C (en) * | 2008-02-29 | 2015-02-10 | Ferrosan Medical Devices A/S | Device for promotion of hemostasis and/or wound healing |
PL3476312T3 (en) | 2008-09-19 | 2024-03-11 | Ethicon Llc | Surgical stapler with apparatus for adjusting staple height |
US9386983B2 (en) | 2008-09-23 | 2016-07-12 | Ethicon Endo-Surgery, Llc | Robotically-controlled motorized surgical instrument |
US8210411B2 (en) | 2008-09-23 | 2012-07-03 | Ethicon Endo-Surgery, Inc. | Motor-driven surgical cutting instrument |
US9005230B2 (en) | 2008-09-23 | 2015-04-14 | Ethicon Endo-Surgery, Inc. | Motorized surgical instrument |
US11648005B2 (en) | 2008-09-23 | 2023-05-16 | Cilag Gmbh International | Robotically-controlled motorized surgical instrument with an end effector |
US8608045B2 (en) | 2008-10-10 | 2013-12-17 | Ethicon Endo-Sugery, Inc. | Powered surgical cutting and stapling apparatus with manually retractable firing system |
US10314935B2 (en) | 2009-01-07 | 2019-06-11 | Entrotech Life Sciences, Inc. | Chlorhexidine-containing antimicrobial laminates |
US8517239B2 (en) | 2009-02-05 | 2013-08-27 | Ethicon Endo-Surgery, Inc. | Surgical stapling instrument comprising a magnetic element driver |
JP2012517287A (en) | 2009-02-06 | 2012-08-02 | エシコン・エンド−サージェリィ・インコーポレイテッド | Improvement of driven surgical stapler |
US8444036B2 (en) | 2009-02-06 | 2013-05-21 | Ethicon Endo-Surgery, Inc. | Motor driven surgical fastener device with mechanisms for adjusting a tissue gap within the end effector |
KR20120033299A (en) | 2009-02-18 | 2012-04-06 | 코매트릭스 카디오바스컬라 인코포레이티드 | Compositions and methods for preventing cardiac arrhythmia |
JP2010213984A (en) * | 2009-03-18 | 2010-09-30 | Naisemu:Kk | In-vivo implanting medical material containing softener and/or moisturizer, method of adjusting content of softener and/or moisturizer in in-vivo implanting medical material, and method for producing in-vivo implanting medical material |
US8968785B2 (en) * | 2009-10-02 | 2015-03-03 | Covidien Lp | Surgical compositions |
US9925140B2 (en) * | 2009-12-22 | 2018-03-27 | National Cheng Kung University | Cell tissue gel containing collagen and hyaluronan |
US8220688B2 (en) | 2009-12-24 | 2012-07-17 | Ethicon Endo-Surgery, Inc. | Motor-driven surgical cutting instrument with electric actuator directional control assembly |
US8851354B2 (en) | 2009-12-24 | 2014-10-07 | Ethicon Endo-Surgery, Inc. | Surgical cutting instrument that analyzes tissue thickness |
CN101791425B (en) * | 2010-03-30 | 2013-04-10 | 赵雪林 | Antibacterial heal-promoting gel material used for preparing medical wound dressing and preparation method thereof |
US9999702B2 (en) | 2010-04-09 | 2018-06-19 | Kci Licensing Inc. | Apparatuses, methods, and compositions for the treatment and prophylaxis of chronic wounds |
US8783543B2 (en) | 2010-07-30 | 2014-07-22 | Ethicon Endo-Surgery, Inc. | Tissue acquisition arrangements and methods for surgical stapling devices |
US9220500B2 (en) | 2010-09-30 | 2015-12-29 | Ethicon Endo-Surgery, Inc. | Tissue thickness compensator comprising structure to produce a resilient load |
US9232941B2 (en) | 2010-09-30 | 2016-01-12 | Ethicon Endo-Surgery, Inc. | Tissue thickness compensator comprising a reservoir |
US9351730B2 (en) | 2011-04-29 | 2016-05-31 | Ethicon Endo-Surgery, Llc | Tissue thickness compensator comprising channels |
US9414838B2 (en) * | 2012-03-28 | 2016-08-16 | Ethicon Endo-Surgery, Llc | Tissue thickness compensator comprised of a plurality of materials |
US9364233B2 (en) | 2010-09-30 | 2016-06-14 | Ethicon Endo-Surgery, Llc | Tissue thickness compensators for circular surgical staplers |
US9307989B2 (en) | 2012-03-28 | 2016-04-12 | Ethicon Endo-Surgery, Llc | Tissue stapler having a thickness compensator incorportating a hydrophobic agent |
US9204880B2 (en) | 2012-03-28 | 2015-12-08 | Ethicon Endo-Surgery, Inc. | Tissue thickness compensator comprising capsules defining a low pressure environment |
US9113865B2 (en) | 2010-09-30 | 2015-08-25 | Ethicon Endo-Surgery, Inc. | Staple cartridge comprising a layer |
US11298125B2 (en) | 2010-09-30 | 2022-04-12 | Cilag Gmbh International | Tissue stapler having a thickness compensator |
US11812965B2 (en) | 2010-09-30 | 2023-11-14 | Cilag Gmbh International | Layer of material for a surgical end effector |
US9700317B2 (en) | 2010-09-30 | 2017-07-11 | Ethicon Endo-Surgery, Llc | Fastener cartridge comprising a releasable tissue thickness compensator |
US9220501B2 (en) | 2010-09-30 | 2015-12-29 | Ethicon Endo-Surgery, Inc. | Tissue thickness compensators |
CA2812553C (en) | 2010-09-30 | 2019-02-12 | Ethicon Endo-Surgery, Inc. | Fastener system comprising a retention matrix and an alignment matrix |
US10945731B2 (en) | 2010-09-30 | 2021-03-16 | Ethicon Llc | Tissue thickness compensator comprising controlled release and expansion |
US9386988B2 (en) | 2010-09-30 | 2016-07-12 | Ethicon End-Surgery, LLC | Retainer assembly including a tissue thickness compensator |
US9332974B2 (en) | 2010-09-30 | 2016-05-10 | Ethicon Endo-Surgery, Llc | Layered tissue thickness compensator |
US9629814B2 (en) | 2010-09-30 | 2017-04-25 | Ethicon Endo-Surgery, Llc | Tissue thickness compensator configured to redistribute compressive forces |
US20120080498A1 (en) | 2010-09-30 | 2012-04-05 | Ethicon Endo-Surgery, Inc. | Curved end effector for a stapling instrument |
US9314246B2 (en) | 2010-09-30 | 2016-04-19 | Ethicon Endo-Surgery, Llc | Tissue stapler having a thickness compensator incorporating an anti-inflammatory agent |
US11925354B2 (en) | 2010-09-30 | 2024-03-12 | Cilag Gmbh International | Staple cartridge comprising staples positioned within a compressible portion thereof |
US8695866B2 (en) | 2010-10-01 | 2014-04-15 | Ethicon Endo-Surgery, Inc. | Surgical instrument having a power control circuit |
US8597264B2 (en) | 2011-03-24 | 2013-12-03 | Kci Licensing, Inc. | Apparatuses, methods, and compositions for the treatment and prophylaxis of chronic wounds |
AU2012250197B2 (en) | 2011-04-29 | 2017-08-10 | Ethicon Endo-Surgery, Inc. | Staple cartridge comprising staples positioned within a compressible portion thereof |
BR112013029300A2 (en) * | 2011-05-13 | 2017-12-19 | Univ Alberta | animal protein polymers and plastics |
US9567502B2 (en) * | 2011-05-13 | 2017-02-14 | The Governors Of The University Of Alberta | Polymers and plastics derived from animal proteins |
KR20140026541A (en) | 2011-05-27 | 2014-03-05 | 코매트릭스 카디오바스컬라 인코포레이티드 | Extracellular matrix material valve conduit and methods of making thereof |
US9072535B2 (en) | 2011-05-27 | 2015-07-07 | Ethicon Endo-Surgery, Inc. | Surgical stapling instruments with rotatable staple deployment arrangements |
US11207064B2 (en) | 2011-05-27 | 2021-12-28 | Cilag Gmbh International | Automated end effector component reloading system for use with a robotic system |
US20120328557A1 (en) * | 2011-06-23 | 2012-12-27 | Excel Med, Llc | Adhesive cell tissue gels |
DE102011107854A1 (en) * | 2011-07-01 | 2013-01-03 | Stefanie Alber | feed |
CN102886062A (en) * | 2011-07-21 | 2013-01-23 | 武汉市三鼎医用生物制品有限公司 | Iodinated chitosan biological antibacterial gel |
US9050084B2 (en) | 2011-09-23 | 2015-06-09 | Ethicon Endo-Surgery, Inc. | Staple cartridge including collapsible deck arrangement |
US9044230B2 (en) | 2012-02-13 | 2015-06-02 | Ethicon Endo-Surgery, Inc. | Surgical cutting and fastening instrument with apparatus for determining cartridge and firing motion status |
CN107617123A (en) * | 2012-02-16 | 2018-01-23 | 技术创新动力基金(以色列)有限合伙公司 | For forming the preparation and kit of bioadhesion matrix |
EP2822474B1 (en) | 2012-03-06 | 2018-05-02 | Ferrosan Medical Devices A/S | Pressurized container containing haemostatic paste |
ITTO20120258A1 (en) | 2012-03-21 | 2013-09-22 | Fond Istituto Italiano Di Tecnologia | POLYMERIC COMPOSITE MATERIALS WITH ANTIMICROBIAL AND BIODEGRADABLE PROPERTIES AND THEIR USES. |
BR112014024098B1 (en) | 2012-03-28 | 2021-05-25 | Ethicon Endo-Surgery, Inc. | staple cartridge |
RU2638273C2 (en) * | 2012-03-28 | 2017-12-12 | Этикон Эндо-Серджери, Инк. | Tissue thickness compensator consisting of multiple materials |
JP6305979B2 (en) | 2012-03-28 | 2018-04-04 | エシコン・エンド−サージェリィ・インコーポレイテッドEthicon Endo−Surgery,Inc. | Tissue thickness compensator with multiple layers |
RU2644272C2 (en) | 2012-03-28 | 2018-02-08 | Этикон Эндо-Серджери, Инк. | Limitation node with tissue thickness compensator |
JP5935181B2 (en) * | 2012-04-24 | 2016-06-15 | カオシュン メディカル ユニヴァーシティ | Biomaterial for wound healing and its preparation |
GB201207617D0 (en) * | 2012-05-02 | 2012-06-13 | Systagenix Wound Man Ip Co Bv | Wound dressings |
CN104349797B (en) | 2012-06-12 | 2017-10-27 | 弗罗桑医疗设备公司 | Dry hemostatic composition |
US9101358B2 (en) | 2012-06-15 | 2015-08-11 | Ethicon Endo-Surgery, Inc. | Articulatable surgical instrument comprising a firing drive |
US11202631B2 (en) | 2012-06-28 | 2021-12-21 | Cilag Gmbh International | Stapling assembly comprising a firing lockout |
US9289256B2 (en) | 2012-06-28 | 2016-03-22 | Ethicon Endo-Surgery, Llc | Surgical end effectors having angled tissue-contacting surfaces |
US9282974B2 (en) | 2012-06-28 | 2016-03-15 | Ethicon Endo-Surgery, Llc | Empty clip cartridge lockout |
US20140001231A1 (en) | 2012-06-28 | 2014-01-02 | Ethicon Endo-Surgery, Inc. | Firing system lockout arrangements for surgical instruments |
JP6290201B2 (en) | 2012-06-28 | 2018-03-07 | エシコン・エンド−サージェリィ・インコーポレイテッドEthicon Endo−Surgery,Inc. | Lockout for empty clip cartridge |
BR112014032776B1 (en) | 2012-06-28 | 2021-09-08 | Ethicon Endo-Surgery, Inc | SURGICAL INSTRUMENT SYSTEM AND SURGICAL KIT FOR USE WITH A SURGICAL INSTRUMENT SYSTEM |
US9408606B2 (en) | 2012-06-28 | 2016-08-09 | Ethicon Endo-Surgery, Llc | Robotically powered surgical device with manually-actuatable reversing system |
US9204879B2 (en) | 2012-06-28 | 2015-12-08 | Ethicon Endo-Surgery, Inc. | Flexible drive member |
US9561135B2 (en) * | 2013-01-02 | 2017-02-07 | Kci Licensing, Inc. | Flexible, adherent, and non-polyurethane film wound drape cover |
US9386984B2 (en) | 2013-02-08 | 2016-07-12 | Ethicon Endo-Surgery, Llc | Staple cartridge comprising a releasable cover |
WO2014127278A2 (en) * | 2013-02-18 | 2014-08-21 | Elutin, Inc. | Site specific drug delivery wraps, systems and methods of use thereof |
US20140249557A1 (en) | 2013-03-01 | 2014-09-04 | Ethicon Endo-Surgery, Inc. | Thumbwheel switch arrangements for surgical instruments |
BR112015021098B1 (en) | 2013-03-01 | 2022-02-15 | Ethicon Endo-Surgery, Inc | COVERAGE FOR A JOINT JOINT AND SURGICAL INSTRUMENT |
RU2669463C2 (en) | 2013-03-01 | 2018-10-11 | Этикон Эндо-Серджери, Инк. | Surgical instrument with soft stop |
US9345481B2 (en) | 2013-03-13 | 2016-05-24 | Ethicon Endo-Surgery, Llc | Staple cartridge tissue thickness sensor system |
US9883860B2 (en) | 2013-03-14 | 2018-02-06 | Ethicon Llc | Interchangeable shaft assemblies for use with a surgical instrument |
US9629629B2 (en) | 2013-03-14 | 2017-04-25 | Ethicon Endo-Surgey, LLC | Control systems for surgical instruments |
EP2976095B1 (en) * | 2013-03-15 | 2020-12-23 | 3M Innovative Properties Company | Wound healing compositions |
US9332984B2 (en) | 2013-03-27 | 2016-05-10 | Ethicon Endo-Surgery, Llc | Fastener cartridge assemblies |
US9572577B2 (en) | 2013-03-27 | 2017-02-21 | Ethicon Endo-Surgery, Llc | Fastener cartridge comprising a tissue thickness compensator including openings therein |
US9795384B2 (en) | 2013-03-27 | 2017-10-24 | Ethicon Llc | Fastener cartridge comprising a tissue thickness compensator and a gap setting element |
BR112015026109B1 (en) | 2013-04-16 | 2022-02-22 | Ethicon Endo-Surgery, Inc | surgical instrument |
US10136887B2 (en) | 2013-04-16 | 2018-11-27 | Ethicon Llc | Drive system decoupling arrangement for a surgical instrument |
US9574644B2 (en) | 2013-05-30 | 2017-02-21 | Ethicon Endo-Surgery, Llc | Power module for use with a surgical instrument |
US9724078B2 (en) | 2013-06-21 | 2017-08-08 | Ferrosan Medical Devices A/S | Vacuum expanded dry composition and syringe for retaining same |
CN103333270B (en) * | 2013-07-02 | 2016-05-11 | 武汉理工大学 | Collagen peptide grafted sodium alginate sulfuric ester, preparation method and its usage |
MX369362B (en) | 2013-08-23 | 2019-11-06 | Ethicon Endo Surgery Llc | Firing member retraction devices for powered surgical instruments. |
US9924942B2 (en) | 2013-08-23 | 2018-03-27 | Ethicon Llc | Motor-powered articulatable surgical instruments |
CA2928963C (en) | 2013-12-11 | 2020-10-27 | Ferrosan Medical Devices A/S | Dry composition comprising an extrusion enhancer |
US20150173756A1 (en) | 2013-12-23 | 2015-06-25 | Ethicon Endo-Surgery, Inc. | Surgical cutting and stapling methods |
US9839428B2 (en) | 2013-12-23 | 2017-12-12 | Ethicon Llc | Surgical cutting and stapling instruments with independent jaw control features |
US9724092B2 (en) | 2013-12-23 | 2017-08-08 | Ethicon Llc | Modular surgical instruments |
US9585662B2 (en) | 2013-12-23 | 2017-03-07 | Ethicon Endo-Surgery, Llc | Fastener cartridge comprising an extendable firing member |
CN103739734A (en) * | 2014-01-14 | 2014-04-23 | 武汉理工大学 | Carboxymethyl carrageenan-collagen peptide, and preparation method and use thereof |
US9962161B2 (en) | 2014-02-12 | 2018-05-08 | Ethicon Llc | Deliverable surgical instrument |
US20140166725A1 (en) | 2014-02-24 | 2014-06-19 | Ethicon Endo-Surgery, Inc. | Staple cartridge including a barbed staple. |
CN106232029B (en) | 2014-02-24 | 2019-04-12 | 伊西康内外科有限责任公司 | Fastening system including firing member locking piece |
US9804618B2 (en) | 2014-03-26 | 2017-10-31 | Ethicon Llc | Systems and methods for controlling a segmented circuit |
US9820738B2 (en) | 2014-03-26 | 2017-11-21 | Ethicon Llc | Surgical instrument comprising interactive systems |
US20150272580A1 (en) | 2014-03-26 | 2015-10-01 | Ethicon Endo-Surgery, Inc. | Verification of number of battery exchanges/procedure count |
BR112016021943B1 (en) | 2014-03-26 | 2022-06-14 | Ethicon Endo-Surgery, Llc | SURGICAL INSTRUMENT FOR USE BY AN OPERATOR IN A SURGICAL PROCEDURE |
US9913642B2 (en) | 2014-03-26 | 2018-03-13 | Ethicon Llc | Surgical instrument comprising a sensor system |
US11185330B2 (en) | 2014-04-16 | 2021-11-30 | Cilag Gmbh International | Fastener cartridge assemblies and staple retainer cover arrangements |
BR112016023825B1 (en) | 2014-04-16 | 2022-08-02 | Ethicon Endo-Surgery, Llc | STAPLE CARTRIDGE FOR USE WITH A SURGICAL STAPLER AND STAPLE CARTRIDGE FOR USE WITH A SURGICAL INSTRUMENT |
JP6532889B2 (en) | 2014-04-16 | 2019-06-19 | エシコン エルエルシーEthicon LLC | Fastener cartridge assembly and staple holder cover arrangement |
US9801628B2 (en) | 2014-09-26 | 2017-10-31 | Ethicon Llc | Surgical staple and driver arrangements for staple cartridges |
US20150297222A1 (en) | 2014-04-16 | 2015-10-22 | Ethicon Endo-Surgery, Inc. | Fastener cartridges including extensions having different configurations |
CN106456176B (en) | 2014-04-16 | 2019-06-28 | 伊西康内外科有限责任公司 | Fastener cartridge including the extension with various configuration |
US11039615B2 (en) | 2014-04-18 | 2021-06-22 | Entrotech Life Sciences, Inc. | Methods of processing chlorhexidine-containing polymerizable compositions and antimicrobial articles formed thereby |
US10045781B2 (en) | 2014-06-13 | 2018-08-14 | Ethicon Llc | Closure lockout systems for surgical instruments |
BR112017004361B1 (en) | 2014-09-05 | 2023-04-11 | Ethicon Llc | ELECTRONIC SYSTEM FOR A SURGICAL INSTRUMENT |
US10135242B2 (en) | 2014-09-05 | 2018-11-20 | Ethicon Llc | Smart cartridge wake up operation and data retention |
US11311294B2 (en) | 2014-09-05 | 2022-04-26 | Cilag Gmbh International | Powered medical device including measurement of closure state of jaws |
US10105142B2 (en) | 2014-09-18 | 2018-10-23 | Ethicon Llc | Surgical stapler with plurality of cutting elements |
US11523821B2 (en) | 2014-09-26 | 2022-12-13 | Cilag Gmbh International | Method for creating a flexible staple line |
MX2017003960A (en) | 2014-09-26 | 2017-12-04 | Ethicon Llc | Surgical stapling buttresses and adjunct materials. |
AU2015333206B2 (en) | 2014-10-13 | 2019-07-11 | Ferrosan Medical Devices A/S. | Dry composition for use in haemostasis and wound healing |
US10076325B2 (en) | 2014-10-13 | 2018-09-18 | Ethicon Llc | Surgical stapling apparatus comprising a tissue stop |
US9924944B2 (en) | 2014-10-16 | 2018-03-27 | Ethicon Llc | Staple cartridge comprising an adjunct material |
US11141153B2 (en) | 2014-10-29 | 2021-10-12 | Cilag Gmbh International | Staple cartridges comprising driver arrangements |
US10517594B2 (en) | 2014-10-29 | 2019-12-31 | Ethicon Llc | Cartridge assemblies for surgical staplers |
US9844376B2 (en) | 2014-11-06 | 2017-12-19 | Ethicon Llc | Staple cartridge comprising a releasable adjunct material |
US10736636B2 (en) | 2014-12-10 | 2020-08-11 | Ethicon Llc | Articulatable surgical instrument system |
US10117649B2 (en) | 2014-12-18 | 2018-11-06 | Ethicon Llc | Surgical instrument assembly comprising a lockable articulation system |
RU2703684C2 (en) | 2014-12-18 | 2019-10-21 | ЭТИКОН ЭНДО-СЕРДЖЕРИ, ЭлЭлСи | Surgical instrument with anvil which is selectively movable relative to staple cartridge around discrete fixed axis |
US9844374B2 (en) | 2014-12-18 | 2017-12-19 | Ethicon Llc | Surgical instrument systems comprising an articulatable end effector and means for adjusting the firing stroke of a firing member |
US9844375B2 (en) | 2014-12-18 | 2017-12-19 | Ethicon Llc | Drive arrangements for articulatable surgical instruments |
US10085748B2 (en) | 2014-12-18 | 2018-10-02 | Ethicon Llc | Locking arrangements for detachable shaft assemblies with articulatable surgical end effectors |
US10188385B2 (en) | 2014-12-18 | 2019-01-29 | Ethicon Llc | Surgical instrument system comprising lockable systems |
US9987000B2 (en) | 2014-12-18 | 2018-06-05 | Ethicon Llc | Surgical instrument assembly comprising a flexible articulation system |
US10004501B2 (en) | 2014-12-18 | 2018-06-26 | Ethicon Llc | Surgical instruments with improved closure arrangements |
RU2705905C2 (en) | 2014-12-24 | 2019-11-12 | Ферросан Медикал Дивайсиз А/С | Syringe for holding and mixing first and second substances |
US11154301B2 (en) | 2015-02-27 | 2021-10-26 | Cilag Gmbh International | Modular stapling assembly |
US10226250B2 (en) | 2015-02-27 | 2019-03-12 | Ethicon Llc | Modular stapling assembly |
US10180463B2 (en) | 2015-02-27 | 2019-01-15 | Ethicon Llc | Surgical apparatus configured to assess whether a performance parameter of the surgical apparatus is within an acceptable performance band |
US10321907B2 (en) | 2015-02-27 | 2019-06-18 | Ethicon Llc | System for monitoring whether a surgical instrument needs to be serviced |
US9924961B2 (en) | 2015-03-06 | 2018-03-27 | Ethicon Endo-Surgery, Llc | Interactive feedback system for powered surgical instruments |
US10617412B2 (en) | 2015-03-06 | 2020-04-14 | Ethicon Llc | System for detecting the mis-insertion of a staple cartridge into a surgical stapler |
US10687806B2 (en) | 2015-03-06 | 2020-06-23 | Ethicon Llc | Adaptive tissue compression techniques to adjust closure rates for multiple tissue types |
US10052044B2 (en) | 2015-03-06 | 2018-08-21 | Ethicon Llc | Time dependent evaluation of sensor data to determine stability, creep, and viscoelastic elements of measures |
US10441279B2 (en) | 2015-03-06 | 2019-10-15 | Ethicon Llc | Multiple level thresholds to modify operation of powered surgical instruments |
US9808246B2 (en) | 2015-03-06 | 2017-11-07 | Ethicon Endo-Surgery, Llc | Method of operating a powered surgical instrument |
US9895148B2 (en) | 2015-03-06 | 2018-02-20 | Ethicon Endo-Surgery, Llc | Monitoring speed control and precision incrementing of motor for powered surgical instruments |
JP2020121162A (en) | 2015-03-06 | 2020-08-13 | エシコン エルエルシーEthicon LLC | Time dependent evaluation of sensor data to determine stability element, creep element and viscoelastic element of measurement |
US10245033B2 (en) | 2015-03-06 | 2019-04-02 | Ethicon Llc | Surgical instrument comprising a lockable battery housing |
US10045776B2 (en) | 2015-03-06 | 2018-08-14 | Ethicon Llc | Control techniques and sub-processor contained within modular shaft with select control processing from handle |
US9901342B2 (en) | 2015-03-06 | 2018-02-27 | Ethicon Endo-Surgery, Llc | Signal and power communication system positioned on a rotatable shaft |
US9993248B2 (en) | 2015-03-06 | 2018-06-12 | Ethicon Endo-Surgery, Llc | Smart sensors with local signal processing |
US10390825B2 (en) | 2015-03-31 | 2019-08-27 | Ethicon Llc | Surgical instrument with progressive rotary drive systems |
RU2604223C1 (en) * | 2015-06-04 | 2016-12-10 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Национальный исследовательский Мордовский государственный университет им. Н.П. Огарёва" | Method for production of protein-polysaccharide biodegradable film |
US10405863B2 (en) | 2015-06-18 | 2019-09-10 | Ethicon Llc | Movable firing beam support arrangements for articulatable surgical instruments |
RU2717356C2 (en) | 2015-07-03 | 2020-03-23 | Ферросан Медикал Дивайсиз А/С | Syringe for holding vacuum in storage state |
US11058425B2 (en) | 2015-08-17 | 2021-07-13 | Ethicon Llc | Implantable layers for a surgical instrument |
US10098642B2 (en) | 2015-08-26 | 2018-10-16 | Ethicon Llc | Surgical staples comprising features for improved fastening of tissue |
BR112018003693B1 (en) | 2015-08-26 | 2022-11-22 | Ethicon Llc | SURGICAL STAPLE CARTRIDGE FOR USE WITH A SURGICAL STAPPING INSTRUMENT |
MX2022006189A (en) | 2015-09-02 | 2022-06-16 | Ethicon Llc | Surgical staple configurations with camming surfaces located between portions supporting surgical staples. |
US10238390B2 (en) | 2015-09-02 | 2019-03-26 | Ethicon Llc | Surgical staple cartridges with driver arrangements for establishing herringbone staple patterns |
US10085751B2 (en) | 2015-09-23 | 2018-10-02 | Ethicon Llc | Surgical stapler having temperature-based motor control |
US10238386B2 (en) | 2015-09-23 | 2019-03-26 | Ethicon Llc | Surgical stapler having motor control based on an electrical parameter related to a motor current |
US10363036B2 (en) | 2015-09-23 | 2019-07-30 | Ethicon Llc | Surgical stapler having force-based motor control |
US10076326B2 (en) | 2015-09-23 | 2018-09-18 | Ethicon Llc | Surgical stapler having current mirror-based motor control |
US10327769B2 (en) | 2015-09-23 | 2019-06-25 | Ethicon Llc | Surgical stapler having motor control based on a drive system component |
US10105139B2 (en) | 2015-09-23 | 2018-10-23 | Ethicon Llc | Surgical stapler having downstream current-based motor control |
US10299878B2 (en) | 2015-09-25 | 2019-05-28 | Ethicon Llc | Implantable adjunct systems for determining adjunct skew |
US10285699B2 (en) | 2015-09-30 | 2019-05-14 | Ethicon Llc | Compressible adjunct |
US10561420B2 (en) | 2015-09-30 | 2020-02-18 | Ethicon Llc | Tubular absorbable constructs |
US11890015B2 (en) | 2015-09-30 | 2024-02-06 | Cilag Gmbh International | Compressible adjunct with crossing spacer fibers |
US10980539B2 (en) | 2015-09-30 | 2021-04-20 | Ethicon Llc | Implantable adjunct comprising bonded layers |
US10368865B2 (en) | 2015-12-30 | 2019-08-06 | Ethicon Llc | Mechanisms for compensating for drivetrain failure in powered surgical instruments |
US10265068B2 (en) | 2015-12-30 | 2019-04-23 | Ethicon Llc | Surgical instruments with separable motors and motor control circuits |
US10292704B2 (en) | 2015-12-30 | 2019-05-21 | Ethicon Llc | Mechanisms for compensating for battery pack failure in powered surgical instruments |
BR112018016098B1 (en) | 2016-02-09 | 2023-02-23 | Ethicon Llc | SURGICAL INSTRUMENT |
US10433837B2 (en) | 2016-02-09 | 2019-10-08 | Ethicon Llc | Surgical instruments with multiple link articulation arrangements |
US11213293B2 (en) | 2016-02-09 | 2022-01-04 | Cilag Gmbh International | Articulatable surgical instruments with single articulation link arrangements |
US11224426B2 (en) | 2016-02-12 | 2022-01-18 | Cilag Gmbh International | Mechanisms for compensating for drivetrain failure in powered surgical instruments |
US10448948B2 (en) | 2016-02-12 | 2019-10-22 | Ethicon Llc | Mechanisms for compensating for drivetrain failure in powered surgical instruments |
US10258331B2 (en) | 2016-02-12 | 2019-04-16 | Ethicon Llc | Mechanisms for compensating for drivetrain failure in powered surgical instruments |
US10617413B2 (en) | 2016-04-01 | 2020-04-14 | Ethicon Llc | Closure system arrangements for surgical cutting and stapling devices with separate and distinct firing shafts |
US10485542B2 (en) | 2016-04-01 | 2019-11-26 | Ethicon Llc | Surgical stapling instrument comprising multiple lockouts |
US10426467B2 (en) | 2016-04-15 | 2019-10-01 | Ethicon Llc | Surgical instrument with detection sensors |
US10492783B2 (en) | 2016-04-15 | 2019-12-03 | Ethicon, Llc | Surgical instrument with improved stop/start control during a firing motion |
US10357247B2 (en) | 2016-04-15 | 2019-07-23 | Ethicon Llc | Surgical instrument with multiple program responses during a firing motion |
US10405859B2 (en) | 2016-04-15 | 2019-09-10 | Ethicon Llc | Surgical instrument with adjustable stop/start control during a firing motion |
US10456137B2 (en) | 2016-04-15 | 2019-10-29 | Ethicon Llc | Staple formation detection mechanisms |
US10335145B2 (en) | 2016-04-15 | 2019-07-02 | Ethicon Llc | Modular surgical instrument with configurable operating mode |
US11179150B2 (en) | 2016-04-15 | 2021-11-23 | Cilag Gmbh International | Systems and methods for controlling a surgical stapling and cutting instrument |
US11607239B2 (en) | 2016-04-15 | 2023-03-21 | Cilag Gmbh International | Systems and methods for controlling a surgical stapling and cutting instrument |
US10828028B2 (en) | 2016-04-15 | 2020-11-10 | Ethicon Llc | Surgical instrument with multiple program responses during a firing motion |
US11317917B2 (en) | 2016-04-18 | 2022-05-03 | Cilag Gmbh International | Surgical stapling system comprising a lockable firing assembly |
US10478181B2 (en) | 2016-04-18 | 2019-11-19 | Ethicon Llc | Cartridge lockout arrangements for rotary powered surgical cutting and stapling instruments |
US20170296173A1 (en) | 2016-04-18 | 2017-10-19 | Ethicon Endo-Surgery, Llc | Method for operating a surgical instrument |
CN105920650B (en) * | 2016-06-20 | 2019-11-26 | 烟台正海生物科技股份有限公司 | A kind of povidone iodine gynecological medical sponge and preparation method thereof |
US10675024B2 (en) | 2016-06-24 | 2020-06-09 | Ethicon Llc | Staple cartridge comprising overdriven staples |
USD847989S1 (en) | 2016-06-24 | 2019-05-07 | Ethicon Llc | Surgical fastener cartridge |
CN109310431B (en) | 2016-06-24 | 2022-03-04 | 伊西康有限责任公司 | Staple cartridge comprising wire staples and punch staples |
USD826405S1 (en) | 2016-06-24 | 2018-08-21 | Ethicon Llc | Surgical fastener |
USD850617S1 (en) | 2016-06-24 | 2019-06-04 | Ethicon Llc | Surgical fastener cartridge |
US11134942B2 (en) | 2016-12-21 | 2021-10-05 | Cilag Gmbh International | Surgical stapling instruments and staple-forming anvils |
CN110099619B (en) | 2016-12-21 | 2022-07-15 | 爱惜康有限责任公司 | Lockout device for surgical end effector and replaceable tool assembly |
US20180168625A1 (en) | 2016-12-21 | 2018-06-21 | Ethicon Endo-Surgery, Llc | Surgical stapling instruments with smart staple cartridges |
US20180168615A1 (en) | 2016-12-21 | 2018-06-21 | Ethicon Endo-Surgery, Llc | Method of deforming staples from two different types of staple cartridges with the same surgical stapling instrument |
JP7010956B2 (en) | 2016-12-21 | 2022-01-26 | エシコン エルエルシー | How to staple tissue |
US10426471B2 (en) | 2016-12-21 | 2019-10-01 | Ethicon Llc | Surgical instrument with multiple failure response modes |
US10945727B2 (en) | 2016-12-21 | 2021-03-16 | Ethicon Llc | Staple cartridge with deformable driver retention features |
US10675026B2 (en) | 2016-12-21 | 2020-06-09 | Ethicon Llc | Methods of stapling tissue |
US20180168608A1 (en) | 2016-12-21 | 2018-06-21 | Ethicon Endo-Surgery, Llc | Surgical instrument system comprising an end effector lockout and a firing assembly lockout |
US10675025B2 (en) | 2016-12-21 | 2020-06-09 | Ethicon Llc | Shaft assembly comprising separately actuatable and retractable systems |
US11684367B2 (en) | 2016-12-21 | 2023-06-27 | Cilag Gmbh International | Stepped assembly having and end-of-life indicator |
US10993715B2 (en) | 2016-12-21 | 2021-05-04 | Ethicon Llc | Staple cartridge comprising staples with different clamping breadths |
US10517595B2 (en) | 2016-12-21 | 2019-12-31 | Ethicon Llc | Jaw actuated lock arrangements for preventing advancement of a firing member in a surgical end effector unless an unfired cartridge is installed in the end effector |
US10856868B2 (en) | 2016-12-21 | 2020-12-08 | Ethicon Llc | Firing member pin configurations |
US10617414B2 (en) | 2016-12-21 | 2020-04-14 | Ethicon Llc | Closure member arrangements for surgical instruments |
US11419606B2 (en) | 2016-12-21 | 2022-08-23 | Cilag Gmbh International | Shaft assembly comprising a clutch configured to adapt the output of a rotary firing member to two different systems |
US10588632B2 (en) | 2016-12-21 | 2020-03-17 | Ethicon Llc | Surgical end effectors and firing members thereof |
US10758229B2 (en) | 2016-12-21 | 2020-09-01 | Ethicon Llc | Surgical instrument comprising improved jaw control |
US10687810B2 (en) | 2016-12-21 | 2020-06-23 | Ethicon Llc | Stepped staple cartridge with tissue retention and gap setting features |
US10893864B2 (en) | 2016-12-21 | 2021-01-19 | Ethicon | Staple cartridges and arrangements of staples and staple cavities therein |
US20180168648A1 (en) | 2016-12-21 | 2018-06-21 | Ethicon Endo-Surgery, Llc | Durability features for end effectors and firing assemblies of surgical stapling instruments |
BR112019011947A2 (en) | 2016-12-21 | 2019-10-29 | Ethicon Llc | surgical stapling systems |
US10588630B2 (en) | 2016-12-21 | 2020-03-17 | Ethicon Llc | Surgical tool assemblies with closure stroke reduction features |
US10682138B2 (en) | 2016-12-21 | 2020-06-16 | Ethicon Llc | Bilaterally asymmetric staple forming pocket pairs |
US11382638B2 (en) | 2017-06-20 | 2022-07-12 | Cilag Gmbh International | Closed loop feedback control of motor velocity of a surgical stapling and cutting instrument based on measured time over a specified displacement distance |
US10779820B2 (en) | 2017-06-20 | 2020-09-22 | Ethicon Llc | Systems and methods for controlling motor speed according to user input for a surgical instrument |
US11071554B2 (en) | 2017-06-20 | 2021-07-27 | Cilag Gmbh International | Closed loop feedback control of motor velocity of a surgical stapling and cutting instrument based on magnitude of velocity error measurements |
US11090046B2 (en) | 2017-06-20 | 2021-08-17 | Cilag Gmbh International | Systems and methods for controlling displacement member motion of a surgical stapling and cutting instrument |
US10980537B2 (en) | 2017-06-20 | 2021-04-20 | Ethicon Llc | Closed loop feedback control of motor velocity of a surgical stapling and cutting instrument based on measured time over a specified number of shaft rotations |
US10624633B2 (en) | 2017-06-20 | 2020-04-21 | Ethicon Llc | Systems and methods for controlling motor velocity of a surgical stapling and cutting instrument |
USD879809S1 (en) | 2017-06-20 | 2020-03-31 | Ethicon Llc | Display panel with changeable graphical user interface |
US11653914B2 (en) | 2017-06-20 | 2023-05-23 | Cilag Gmbh International | Systems and methods for controlling motor velocity of a surgical stapling and cutting instrument according to articulation angle of end effector |
US10646220B2 (en) | 2017-06-20 | 2020-05-12 | Ethicon Llc | Systems and methods for controlling displacement member velocity for a surgical instrument |
US10307170B2 (en) | 2017-06-20 | 2019-06-04 | Ethicon Llc | Method for closed loop control of motor velocity of a surgical stapling and cutting instrument |
USD890784S1 (en) | 2017-06-20 | 2020-07-21 | Ethicon Llc | Display panel with changeable graphical user interface |
USD879808S1 (en) | 2017-06-20 | 2020-03-31 | Ethicon Llc | Display panel with graphical user interface |
US10368864B2 (en) | 2017-06-20 | 2019-08-06 | Ethicon Llc | Systems and methods for controlling displaying motor velocity for a surgical instrument |
US10881396B2 (en) | 2017-06-20 | 2021-01-05 | Ethicon Llc | Surgical instrument with variable duration trigger arrangement |
US10390841B2 (en) | 2017-06-20 | 2019-08-27 | Ethicon Llc | Control of motor velocity of a surgical stapling and cutting instrument based on angle of articulation |
US11517325B2 (en) | 2017-06-20 | 2022-12-06 | Cilag Gmbh International | Closed loop feedback control of motor velocity of a surgical stapling and cutting instrument based on measured displacement distance traveled over a specified time interval |
US10327767B2 (en) | 2017-06-20 | 2019-06-25 | Ethicon Llc | Control of motor velocity of a surgical stapling and cutting instrument based on angle of articulation |
US10813639B2 (en) | 2017-06-20 | 2020-10-27 | Ethicon Llc | Closed loop feedback control of motor velocity of a surgical stapling and cutting instrument based on system conditions |
US10881399B2 (en) | 2017-06-20 | 2021-01-05 | Ethicon Llc | Techniques for adaptive control of motor velocity of a surgical stapling and cutting instrument |
US10888321B2 (en) | 2017-06-20 | 2021-01-12 | Ethicon Llc | Systems and methods for controlling velocity of a displacement member of a surgical stapling and cutting instrument |
US11266405B2 (en) | 2017-06-27 | 2022-03-08 | Cilag Gmbh International | Surgical anvil manufacturing methods |
US10772629B2 (en) | 2017-06-27 | 2020-09-15 | Ethicon Llc | Surgical anvil arrangements |
US10993716B2 (en) | 2017-06-27 | 2021-05-04 | Ethicon Llc | Surgical anvil arrangements |
US11324503B2 (en) | 2017-06-27 | 2022-05-10 | Cilag Gmbh International | Surgical firing member arrangements |
US10856869B2 (en) | 2017-06-27 | 2020-12-08 | Ethicon Llc | Surgical anvil arrangements |
US20180368844A1 (en) | 2017-06-27 | 2018-12-27 | Ethicon Llc | Staple forming pocket arrangements |
US11564686B2 (en) | 2017-06-28 | 2023-01-31 | Cilag Gmbh International | Surgical shaft assemblies with flexible interfaces |
US11246592B2 (en) | 2017-06-28 | 2022-02-15 | Cilag Gmbh International | Surgical instrument comprising an articulation system lockable to a frame |
USD851762S1 (en) | 2017-06-28 | 2019-06-18 | Ethicon Llc | Anvil |
US11259805B2 (en) | 2017-06-28 | 2022-03-01 | Cilag Gmbh International | Surgical instrument comprising firing member supports |
US10211586B2 (en) | 2017-06-28 | 2019-02-19 | Ethicon Llc | Surgical shaft assemblies with watertight housings |
USD906355S1 (en) | 2017-06-28 | 2020-12-29 | Ethicon Llc | Display screen or portion thereof with a graphical user interface for a surgical instrument |
US10903685B2 (en) | 2017-06-28 | 2021-01-26 | Ethicon Llc | Surgical shaft assemblies with slip ring assemblies forming capacitive channels |
USD854151S1 (en) | 2017-06-28 | 2019-07-16 | Ethicon Llc | Surgical instrument shaft |
US10765427B2 (en) | 2017-06-28 | 2020-09-08 | Ethicon Llc | Method for articulating a surgical instrument |
USD869655S1 (en) | 2017-06-28 | 2019-12-10 | Ethicon Llc | Surgical fastener cartridge |
US11020114B2 (en) | 2017-06-28 | 2021-06-01 | Cilag Gmbh International | Surgical instruments with articulatable end effector with axially shortened articulation joint configurations |
EP3420947B1 (en) | 2017-06-28 | 2022-05-25 | Cilag GmbH International | Surgical instrument comprising selectively actuatable rotatable couplers |
US10716614B2 (en) | 2017-06-28 | 2020-07-21 | Ethicon Llc | Surgical shaft assemblies with slip ring assemblies with increased contact pressure |
US11678880B2 (en) | 2017-06-28 | 2023-06-20 | Cilag Gmbh International | Surgical instrument comprising a shaft including a housing arrangement |
US10898183B2 (en) | 2017-06-29 | 2021-01-26 | Ethicon Llc | Robotic surgical instrument with closed loop feedback techniques for advancement of closure member during firing |
US10398434B2 (en) | 2017-06-29 | 2019-09-03 | Ethicon Llc | Closed loop velocity control of closure member for robotic surgical instrument |
US11007022B2 (en) | 2017-06-29 | 2021-05-18 | Ethicon Llc | Closed loop velocity control techniques based on sensed tissue parameters for robotic surgical instrument |
US10258418B2 (en) | 2017-06-29 | 2019-04-16 | Ethicon Llc | System for controlling articulation forces |
US10932772B2 (en) | 2017-06-29 | 2021-03-02 | Ethicon Llc | Methods for closed loop velocity control for robotic surgical instrument |
KR102038560B1 (en) * | 2017-07-19 | 2019-11-01 | 순천향대학교 산학협력단 | A preparation method of an porous hemostatic agent using wood based-oxidized cellulose and silk fibroin |
US11944300B2 (en) | 2017-08-03 | 2024-04-02 | Cilag Gmbh International | Method for operating a surgical system bailout |
US11471155B2 (en) | 2017-08-03 | 2022-10-18 | Cilag Gmbh International | Surgical system bailout |
US11304695B2 (en) | 2017-08-03 | 2022-04-19 | Cilag Gmbh International | Surgical system shaft interconnection |
US11399829B2 (en) | 2017-09-29 | 2022-08-02 | Cilag Gmbh International | Systems and methods of initiating a power shutdown mode for a surgical instrument |
US10796471B2 (en) | 2017-09-29 | 2020-10-06 | Ethicon Llc | Systems and methods of displaying a knife position for a surgical instrument |
USD917500S1 (en) | 2017-09-29 | 2021-04-27 | Ethicon Llc | Display screen or portion thereof with graphical user interface |
USD907647S1 (en) | 2017-09-29 | 2021-01-12 | Ethicon Llc | Display screen or portion thereof with animated graphical user interface |
US10743872B2 (en) | 2017-09-29 | 2020-08-18 | Ethicon Llc | System and methods for controlling a display of a surgical instrument |
US10765429B2 (en) | 2017-09-29 | 2020-09-08 | Ethicon Llc | Systems and methods for providing alerts according to the operational state of a surgical instrument |
USD907648S1 (en) | 2017-09-29 | 2021-01-12 | Ethicon Llc | Display screen or portion thereof with animated graphical user interface |
US10729501B2 (en) | 2017-09-29 | 2020-08-04 | Ethicon Llc | Systems and methods for language selection of a surgical instrument |
US11090075B2 (en) | 2017-10-30 | 2021-08-17 | Cilag Gmbh International | Articulation features for surgical end effector |
US11134944B2 (en) | 2017-10-30 | 2021-10-05 | Cilag Gmbh International | Surgical stapler knife motion controls |
US10779903B2 (en) | 2017-10-31 | 2020-09-22 | Ethicon Llc | Positive shaft rotation lock activated by jaw closure |
US10842490B2 (en) | 2017-10-31 | 2020-11-24 | Ethicon Llc | Cartridge body design with force reduction based on firing completion |
US11006955B2 (en) | 2017-12-15 | 2021-05-18 | Ethicon Llc | End effectors with positive jaw opening features for use with adapters for electromechanical surgical instruments |
US10828033B2 (en) | 2017-12-15 | 2020-11-10 | Ethicon Llc | Handheld electromechanical surgical instruments with improved motor control arrangements for positioning components of an adapter coupled thereto |
US10779825B2 (en) | 2017-12-15 | 2020-09-22 | Ethicon Llc | Adapters with end effector position sensing and control arrangements for use in connection with electromechanical surgical instruments |
US10743875B2 (en) | 2017-12-15 | 2020-08-18 | Ethicon Llc | Surgical end effectors with jaw stiffener arrangements configured to permit monitoring of firing member |
US10687813B2 (en) | 2017-12-15 | 2020-06-23 | Ethicon Llc | Adapters with firing stroke sensing arrangements for use in connection with electromechanical surgical instruments |
US11071543B2 (en) | 2017-12-15 | 2021-07-27 | Cilag Gmbh International | Surgical end effectors with clamping assemblies configured to increase jaw aperture ranges |
US11033267B2 (en) | 2017-12-15 | 2021-06-15 | Ethicon Llc | Systems and methods of controlling a clamping member firing rate of a surgical instrument |
US10779826B2 (en) | 2017-12-15 | 2020-09-22 | Ethicon Llc | Methods of operating surgical end effectors |
US10869666B2 (en) | 2017-12-15 | 2020-12-22 | Ethicon Llc | Adapters with control systems for controlling multiple motors of an electromechanical surgical instrument |
US10743874B2 (en) | 2017-12-15 | 2020-08-18 | Ethicon Llc | Sealed adapters for use with electromechanical surgical instruments |
US10966718B2 (en) | 2017-12-15 | 2021-04-06 | Ethicon Llc | Dynamic clamping assemblies with improved wear characteristics for use in connection with electromechanical surgical instruments |
US11197670B2 (en) | 2017-12-15 | 2021-12-14 | Cilag Gmbh International | Surgical end effectors with pivotal jaws configured to touch at their respective distal ends when fully closed |
USD910847S1 (en) | 2017-12-19 | 2021-02-16 | Ethicon Llc | Surgical instrument assembly |
US10835330B2 (en) | 2017-12-19 | 2020-11-17 | Ethicon Llc | Method for determining the position of a rotatable jaw of a surgical instrument attachment assembly |
US10716565B2 (en) | 2017-12-19 | 2020-07-21 | Ethicon Llc | Surgical instruments with dual articulation drivers |
US10729509B2 (en) | 2017-12-19 | 2020-08-04 | Ethicon Llc | Surgical instrument comprising closure and firing locking mechanism |
US11045270B2 (en) | 2017-12-19 | 2021-06-29 | Cilag Gmbh International | Robotic attachment comprising exterior drive actuator |
US11020112B2 (en) | 2017-12-19 | 2021-06-01 | Ethicon Llc | Surgical tools configured for interchangeable use with different controller interfaces |
US11076853B2 (en) | 2017-12-21 | 2021-08-03 | Cilag Gmbh International | Systems and methods of displaying a knife position during transection for a surgical instrument |
US11311290B2 (en) | 2017-12-21 | 2022-04-26 | Cilag Gmbh International | Surgical instrument comprising an end effector dampener |
US11129680B2 (en) | 2017-12-21 | 2021-09-28 | Cilag Gmbh International | Surgical instrument comprising a projector |
US11179151B2 (en) | 2017-12-21 | 2021-11-23 | Cilag Gmbh International | Surgical instrument comprising a display |
CN108144100A (en) * | 2017-12-28 | 2018-06-12 | 广州润虹医药科技股份有限公司 | A kind of Wound dressing for promoting wound healing and preparation method thereof |
CN108478849B (en) * | 2018-02-07 | 2021-04-16 | 广州迈普再生医学科技股份有限公司 | Absorbable and adherable hemostatic sponge and preparation method thereof |
JP7395113B2 (en) | 2018-05-09 | 2023-12-11 | フェロサン メディカル デバイシーズ エイ/エス | Method of preparing a hemostatic composition |
US11207065B2 (en) | 2018-08-20 | 2021-12-28 | Cilag Gmbh International | Method for fabricating surgical stapler anvils |
US11324501B2 (en) | 2018-08-20 | 2022-05-10 | Cilag Gmbh International | Surgical stapling devices with improved closure members |
US11253256B2 (en) | 2018-08-20 | 2022-02-22 | Cilag Gmbh International | Articulatable motor powered surgical instruments with dedicated articulation motor arrangements |
US11083458B2 (en) | 2018-08-20 | 2021-08-10 | Cilag Gmbh International | Powered surgical instruments with clutching arrangements to convert linear drive motions to rotary drive motions |
USD914878S1 (en) | 2018-08-20 | 2021-03-30 | Ethicon Llc | Surgical instrument anvil |
US10856870B2 (en) | 2018-08-20 | 2020-12-08 | Ethicon Llc | Switching arrangements for motor powered articulatable surgical instruments |
US11039834B2 (en) | 2018-08-20 | 2021-06-22 | Cilag Gmbh International | Surgical stapler anvils with staple directing protrusions and tissue stability features |
US11045192B2 (en) | 2018-08-20 | 2021-06-29 | Cilag Gmbh International | Fabricating techniques for surgical stapler anvils |
US11291440B2 (en) | 2018-08-20 | 2022-04-05 | Cilag Gmbh International | Method for operating a powered articulatable surgical instrument |
US10912559B2 (en) | 2018-08-20 | 2021-02-09 | Ethicon Llc | Reinforced deformable anvil tip for surgical stapler anvil |
US10779821B2 (en) | 2018-08-20 | 2020-09-22 | Ethicon Llc | Surgical stapler anvils with tissue stop features configured to avoid tissue pinch |
US10842492B2 (en) | 2018-08-20 | 2020-11-24 | Ethicon Llc | Powered articulatable surgical instruments with clutching and locking arrangements for linking an articulation drive system to a firing drive system |
WO2020087181A1 (en) * | 2018-11-02 | 2020-05-07 | Covalon Technologies Inc. | Foam compositions, foam matrices and methods |
CN109939260A (en) * | 2019-03-01 | 2019-06-28 | 昆明理工大学 | A kind of preparation method of medical chitosan/Sodium Hyaluronate coupling hydrogel |
US11696761B2 (en) | 2019-03-25 | 2023-07-11 | Cilag Gmbh International | Firing drive arrangements for surgical systems |
US11147551B2 (en) | 2019-03-25 | 2021-10-19 | Cilag Gmbh International | Firing drive arrangements for surgical systems |
US11172929B2 (en) | 2019-03-25 | 2021-11-16 | Cilag Gmbh International | Articulation drive arrangements for surgical systems |
US11147553B2 (en) | 2019-03-25 | 2021-10-19 | Cilag Gmbh International | Firing drive arrangements for surgical systems |
US11426251B2 (en) | 2019-04-30 | 2022-08-30 | Cilag Gmbh International | Articulation directional lights on a surgical instrument |
US11903581B2 (en) | 2019-04-30 | 2024-02-20 | Cilag Gmbh International | Methods for stapling tissue using a surgical instrument |
US11452528B2 (en) | 2019-04-30 | 2022-09-27 | Cilag Gmbh International | Articulation actuators for a surgical instrument |
US11432816B2 (en) | 2019-04-30 | 2022-09-06 | Cilag Gmbh International | Articulation pin for a surgical instrument |
US11471157B2 (en) | 2019-04-30 | 2022-10-18 | Cilag Gmbh International | Articulation control mapping for a surgical instrument |
US11253254B2 (en) | 2019-04-30 | 2022-02-22 | Cilag Gmbh International | Shaft rotation actuator on a surgical instrument |
US11648009B2 (en) | 2019-04-30 | 2023-05-16 | Cilag Gmbh International | Rotatable jaw tip for a surgical instrument |
US11771419B2 (en) | 2019-06-28 | 2023-10-03 | Cilag Gmbh International | Packaging for a replaceable component of a surgical stapling system |
US11497492B2 (en) | 2019-06-28 | 2022-11-15 | Cilag Gmbh International | Surgical instrument including an articulation lock |
US11224497B2 (en) | 2019-06-28 | 2022-01-18 | Cilag Gmbh International | Surgical systems with multiple RFID tags |
US11291451B2 (en) | 2019-06-28 | 2022-04-05 | Cilag Gmbh International | Surgical instrument with battery compatibility verification functionality |
US11259803B2 (en) | 2019-06-28 | 2022-03-01 | Cilag Gmbh International | Surgical stapling system having an information encryption protocol |
US11426167B2 (en) | 2019-06-28 | 2022-08-30 | Cilag Gmbh International | Mechanisms for proper anvil attachment surgical stapling head assembly |
US11523822B2 (en) | 2019-06-28 | 2022-12-13 | Cilag Gmbh International | Battery pack including a circuit interrupter |
US11246678B2 (en) | 2019-06-28 | 2022-02-15 | Cilag Gmbh International | Surgical stapling system having a frangible RFID tag |
US11478241B2 (en) | 2019-06-28 | 2022-10-25 | Cilag Gmbh International | Staple cartridge including projections |
US11229437B2 (en) | 2019-06-28 | 2022-01-25 | Cilag Gmbh International | Method for authenticating the compatibility of a staple cartridge with a surgical instrument |
US11051807B2 (en) | 2019-06-28 | 2021-07-06 | Cilag Gmbh International | Packaging assembly including a particulate trap |
US11638587B2 (en) | 2019-06-28 | 2023-05-02 | Cilag Gmbh International | RFID identification systems for surgical instruments |
US11219455B2 (en) | 2019-06-28 | 2022-01-11 | Cilag Gmbh International | Surgical instrument including a lockout key |
US11684434B2 (en) | 2019-06-28 | 2023-06-27 | Cilag Gmbh International | Surgical RFID assemblies for instrument operational setting control |
US11553971B2 (en) | 2019-06-28 | 2023-01-17 | Cilag Gmbh International | Surgical RFID assemblies for display and communication |
US11298127B2 (en) | 2019-06-28 | 2022-04-12 | Cilag GmbH Interational | Surgical stapling system having a lockout mechanism for an incompatible cartridge |
US11627959B2 (en) | 2019-06-28 | 2023-04-18 | Cilag Gmbh International | Surgical instruments including manual and powered system lockouts |
US11298132B2 (en) | 2019-06-28 | 2022-04-12 | Cilag GmbH Inlernational | Staple cartridge including a honeycomb extension |
US11660163B2 (en) | 2019-06-28 | 2023-05-30 | Cilag Gmbh International | Surgical system with RFID tags for updating motor assembly parameters |
US11464601B2 (en) | 2019-06-28 | 2022-10-11 | Cilag Gmbh International | Surgical instrument comprising an RFID system for tracking a movable component |
US11376098B2 (en) | 2019-06-28 | 2022-07-05 | Cilag Gmbh International | Surgical instrument system comprising an RFID system |
US11399837B2 (en) | 2019-06-28 | 2022-08-02 | Cilag Gmbh International | Mechanisms for motor control adjustments of a motorized surgical instrument |
MX2022007290A (en) | 2019-12-17 | 2022-09-19 | Covalon Tech Ltd | Reactors for coating devices and related systems and methods. |
US11529139B2 (en) | 2019-12-19 | 2022-12-20 | Cilag Gmbh International | Motor driven surgical instrument |
US11504122B2 (en) | 2019-12-19 | 2022-11-22 | Cilag Gmbh International | Surgical instrument comprising a nested firing member |
US11911032B2 (en) | 2019-12-19 | 2024-02-27 | Cilag Gmbh International | Staple cartridge comprising a seating cam |
US11446029B2 (en) | 2019-12-19 | 2022-09-20 | Cilag Gmbh International | Staple cartridge comprising projections extending from a curved deck surface |
US11701111B2 (en) | 2019-12-19 | 2023-07-18 | Cilag Gmbh International | Method for operating a surgical stapling instrument |
US11607219B2 (en) | 2019-12-19 | 2023-03-21 | Cilag Gmbh International | Staple cartridge comprising a detachable tissue cutting knife |
US11559304B2 (en) | 2019-12-19 | 2023-01-24 | Cilag Gmbh International | Surgical instrument comprising a rapid closure mechanism |
US11304696B2 (en) | 2019-12-19 | 2022-04-19 | Cilag Gmbh International | Surgical instrument comprising a powered articulation system |
US11234698B2 (en) | 2019-12-19 | 2022-02-01 | Cilag Gmbh International | Stapling system comprising a clamp lockout and a firing lockout |
US11291447B2 (en) | 2019-12-19 | 2022-04-05 | Cilag Gmbh International | Stapling instrument comprising independent jaw closing and staple firing systems |
US11464512B2 (en) | 2019-12-19 | 2022-10-11 | Cilag Gmbh International | Staple cartridge comprising a curved deck surface |
US11529137B2 (en) | 2019-12-19 | 2022-12-20 | Cilag Gmbh International | Staple cartridge comprising driver retention members |
US11931033B2 (en) | 2019-12-19 | 2024-03-19 | Cilag Gmbh International | Staple cartridge comprising a latch lockout |
US11844520B2 (en) | 2019-12-19 | 2023-12-19 | Cilag Gmbh International | Staple cartridge comprising driver retention members |
US11576672B2 (en) | 2019-12-19 | 2023-02-14 | Cilag Gmbh International | Surgical instrument comprising a closure system including a closure member and an opening member driven by a drive screw |
USD975850S1 (en) | 2020-06-02 | 2023-01-17 | Cilag Gmbh International | Staple cartridge |
USD975851S1 (en) | 2020-06-02 | 2023-01-17 | Cilag Gmbh International | Staple cartridge |
USD976401S1 (en) | 2020-06-02 | 2023-01-24 | Cilag Gmbh International | Staple cartridge |
USD975278S1 (en) | 2020-06-02 | 2023-01-10 | Cilag Gmbh International | Staple cartridge |
USD967421S1 (en) | 2020-06-02 | 2022-10-18 | Cilag Gmbh International | Staple cartridge |
USD974560S1 (en) | 2020-06-02 | 2023-01-03 | Cilag Gmbh International | Staple cartridge |
USD966512S1 (en) | 2020-06-02 | 2022-10-11 | Cilag Gmbh International | Staple cartridge |
US20220031350A1 (en) | 2020-07-28 | 2022-02-03 | Cilag Gmbh International | Surgical instruments with double pivot articulation joint arrangements |
RU2747662C1 (en) * | 2020-09-03 | 2021-05-11 | Эльдар Рифович Бакиров | Method for strengthening inter-intestinal anastomoses |
US11517390B2 (en) | 2020-10-29 | 2022-12-06 | Cilag Gmbh International | Surgical instrument comprising a limited travel switch |
US11534259B2 (en) | 2020-10-29 | 2022-12-27 | Cilag Gmbh International | Surgical instrument comprising an articulation indicator |
US11844518B2 (en) | 2020-10-29 | 2023-12-19 | Cilag Gmbh International | Method for operating a surgical instrument |
US11617577B2 (en) | 2020-10-29 | 2023-04-04 | Cilag Gmbh International | Surgical instrument comprising a sensor configured to sense whether an articulation drive of the surgical instrument is actuatable |
US11452526B2 (en) | 2020-10-29 | 2022-09-27 | Cilag Gmbh International | Surgical instrument comprising a staged voltage regulation start-up system |
US11931025B2 (en) | 2020-10-29 | 2024-03-19 | Cilag Gmbh International | Surgical instrument comprising a releasable closure drive lock |
US11779330B2 (en) | 2020-10-29 | 2023-10-10 | Cilag Gmbh International | Surgical instrument comprising a jaw alignment system |
US11717289B2 (en) | 2020-10-29 | 2023-08-08 | Cilag Gmbh International | Surgical instrument comprising an indicator which indicates that an articulation drive is actuatable |
USD980425S1 (en) | 2020-10-29 | 2023-03-07 | Cilag Gmbh International | Surgical instrument assembly |
USD1013170S1 (en) | 2020-10-29 | 2024-01-30 | Cilag Gmbh International | Surgical instrument assembly |
US11896217B2 (en) | 2020-10-29 | 2024-02-13 | Cilag Gmbh International | Surgical instrument comprising an articulation lock |
US11627960B2 (en) | 2020-12-02 | 2023-04-18 | Cilag Gmbh International | Powered surgical instruments with smart reload with separately attachable exteriorly mounted wiring connections |
US11653920B2 (en) | 2020-12-02 | 2023-05-23 | Cilag Gmbh International | Powered surgical instruments with communication interfaces through sterile barrier |
US11944296B2 (en) | 2020-12-02 | 2024-04-02 | Cilag Gmbh International | Powered surgical instruments with external connectors |
US11653915B2 (en) | 2020-12-02 | 2023-05-23 | Cilag Gmbh International | Surgical instruments with sled location detection and adjustment features |
US11890010B2 (en) | 2020-12-02 | 2024-02-06 | Cllag GmbH International | Dual-sided reinforced reload for surgical instruments |
US11737751B2 (en) | 2020-12-02 | 2023-08-29 | Cilag Gmbh International | Devices and methods of managing energy dissipated within sterile barriers of surgical instrument housings |
US11744581B2 (en) | 2020-12-02 | 2023-09-05 | Cilag Gmbh International | Powered surgical instruments with multi-phase tissue treatment |
US11678882B2 (en) | 2020-12-02 | 2023-06-20 | Cilag Gmbh International | Surgical instruments with interactive features to remedy incidental sled movements |
US11849943B2 (en) | 2020-12-02 | 2023-12-26 | Cilag Gmbh International | Surgical instrument with cartridge release mechanisms |
US11812964B2 (en) | 2021-02-26 | 2023-11-14 | Cilag Gmbh International | Staple cartridge comprising a power management circuit |
US11723657B2 (en) | 2021-02-26 | 2023-08-15 | Cilag Gmbh International | Adjustable communication based on available bandwidth and power capacity |
US11751869B2 (en) | 2021-02-26 | 2023-09-12 | Cilag Gmbh International | Monitoring of multiple sensors over time to detect moving characteristics of tissue |
US11925349B2 (en) | 2021-02-26 | 2024-03-12 | Cilag Gmbh International | Adjustment to transfer parameters to improve available power |
US11730473B2 (en) | 2021-02-26 | 2023-08-22 | Cilag Gmbh International | Monitoring of manufacturing life-cycle |
US11793514B2 (en) | 2021-02-26 | 2023-10-24 | Cilag Gmbh International | Staple cartridge comprising sensor array which may be embedded in cartridge body |
US11696757B2 (en) | 2021-02-26 | 2023-07-11 | Cilag Gmbh International | Monitoring of internal systems to detect and track cartridge motion status |
US11744583B2 (en) | 2021-02-26 | 2023-09-05 | Cilag Gmbh International | Distal communication array to tune frequency of RF systems |
US11701113B2 (en) | 2021-02-26 | 2023-07-18 | Cilag Gmbh International | Stapling instrument comprising a separate power antenna and a data transfer antenna |
US11749877B2 (en) | 2021-02-26 | 2023-09-05 | Cilag Gmbh International | Stapling instrument comprising a signal antenna |
US11826042B2 (en) | 2021-03-22 | 2023-11-28 | Cilag Gmbh International | Surgical instrument comprising a firing drive including a selectable leverage mechanism |
US11717291B2 (en) | 2021-03-22 | 2023-08-08 | Cilag Gmbh International | Staple cartridge comprising staples configured to apply different tissue compression |
US11737749B2 (en) | 2021-03-22 | 2023-08-29 | Cilag Gmbh International | Surgical stapling instrument comprising a retraction system |
US11806011B2 (en) | 2021-03-22 | 2023-11-07 | Cilag Gmbh International | Stapling instrument comprising tissue compression systems |
US11759202B2 (en) | 2021-03-22 | 2023-09-19 | Cilag Gmbh International | Staple cartridge comprising an implantable layer |
US11723658B2 (en) | 2021-03-22 | 2023-08-15 | Cilag Gmbh International | Staple cartridge comprising a firing lockout |
US11826012B2 (en) | 2021-03-22 | 2023-11-28 | Cilag Gmbh International | Stapling instrument comprising a pulsed motor-driven firing rack |
US11849945B2 (en) | 2021-03-24 | 2023-12-26 | Cilag Gmbh International | Rotary-driven surgical stapling assembly comprising eccentrically driven firing member |
US11793516B2 (en) | 2021-03-24 | 2023-10-24 | Cilag Gmbh International | Surgical staple cartridge comprising longitudinal support beam |
US11944336B2 (en) | 2021-03-24 | 2024-04-02 | Cilag Gmbh International | Joint arrangements for multi-planar alignment and support of operational drive shafts in articulatable surgical instruments |
US11896219B2 (en) | 2021-03-24 | 2024-02-13 | Cilag Gmbh International | Mating features between drivers and underside of a cartridge deck |
US11896218B2 (en) | 2021-03-24 | 2024-02-13 | Cilag Gmbh International | Method of using a powered stapling device |
US11786243B2 (en) | 2021-03-24 | 2023-10-17 | Cilag Gmbh International | Firing members having flexible portions for adapting to a load during a surgical firing stroke |
US11786239B2 (en) | 2021-03-24 | 2023-10-17 | Cilag Gmbh International | Surgical instrument articulation joint arrangements comprising multiple moving linkage features |
US11857183B2 (en) | 2021-03-24 | 2024-01-02 | Cilag Gmbh International | Stapling assembly components having metal substrates and plastic bodies |
US11744603B2 (en) | 2021-03-24 | 2023-09-05 | Cilag Gmbh International | Multi-axis pivot joints for surgical instruments and methods for manufacturing same |
US11849944B2 (en) | 2021-03-24 | 2023-12-26 | Cilag Gmbh International | Drivers for fastener cartridge assemblies having rotary drive screws |
US11903582B2 (en) | 2021-03-24 | 2024-02-20 | Cilag Gmbh International | Leveraging surfaces for cartridge installation |
US11832816B2 (en) | 2021-03-24 | 2023-12-05 | Cilag Gmbh International | Surgical stapling assembly comprising nonplanar staples and planar staples |
US20220378426A1 (en) | 2021-05-28 | 2022-12-01 | Cilag Gmbh International | Stapling instrument comprising a mounted shaft orientation sensor |
CN113577373A (en) * | 2021-07-30 | 2021-11-02 | 南京嘉合玉颜生物科技有限公司 | Preparation method of absorbable gelatin sponge |
US11877745B2 (en) | 2021-10-18 | 2024-01-23 | Cilag Gmbh International | Surgical stapling assembly having longitudinally-repeating staple leg clusters |
US11937816B2 (en) | 2021-10-28 | 2024-03-26 | Cilag Gmbh International | Electrical lead arrangements for surgical instruments |
CN114533948A (en) * | 2022-02-25 | 2022-05-27 | 韩友平 | Biomedical gel and preparation method thereof |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3491760A (en) * | 1965-07-09 | 1970-01-27 | Braun Intern Gmbh B | Wound coverings |
US4703108A (en) * | 1984-03-27 | 1987-10-27 | University Of Medicine & Dentistry Of New Jersey | Biodegradable matrix and methods for producing same |
US5399361A (en) * | 1992-05-01 | 1995-03-21 | Amgen Inc. | Collagen-containing sponges as drug delivery compositions for proteins |
US5550187A (en) * | 1988-11-21 | 1996-08-27 | Collagen Corporation | Method of preparing crosslinked biomaterial compositions for use in tissue augmentation |
US5744545A (en) * | 1988-11-21 | 1998-04-28 | Collagen Corporation | Biocompatible adhesive compositions |
US6132765A (en) * | 1996-04-12 | 2000-10-17 | Uroteq Inc. | Drug delivery via therapeutic hydrogels |
US20020131933A1 (en) * | 1996-01-16 | 2002-09-19 | Yves Delmotte | Biopolymer membrane and methods for its preparation |
US20030039695A1 (en) * | 2001-08-10 | 2003-02-27 | Ed. Geistlich Soehne Ag Fuer Chemische Industrie | Collagen carrier of therapeutic genetic material, and method |
US20060068013A1 (en) * | 2004-09-30 | 2006-03-30 | Ditizio Valerio | Non-adhesive elastic gelatin matrices |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA409076A (en) * | 1942-12-01 | Lionel Daniels Joseph | Chain type sawing machine | |
US3491780A (en) * | 1967-12-11 | 1970-01-27 | Maytag Co | Self-cleaning filter for dishwasher |
US4925924A (en) | 1984-03-27 | 1990-05-15 | University Of Medicine And Dentistry Of New Jersey | Biocompatible synthetic and collagen compositions having a dual-type porosity for treatment of wounds and pressure ulcers and therapeutic methods thereof |
US5475052A (en) * | 1988-11-21 | 1995-12-12 | Collagen Corporation | Collagen-synthetic polymer matrices prepared using a multiple step reaction |
RU2033149C1 (en) * | 1990-02-09 | 1995-04-20 | Ленинградский научно-исследовательский институт гематологии и переливания крови | Method for making hemostatic preparation |
JPH03286772A (en) * | 1990-03-31 | 1991-12-17 | Sanwa Kagaku Kenkyusho Co Ltd | Coating material for treating wound |
NL9200683A (en) | 1992-04-13 | 1993-11-01 | Thyssen De Reus Bv | MECHANISM FOR LOCKING A SWIVEL AXIS LIKE A HINGE AXIS FOR AN ELEVATOR DOOR. |
RU2034572C1 (en) * | 1992-11-03 | 1995-05-10 | Малое многопрофильное предприятие "ПОЛИКОМ" | Hemostatic sponge |
US5492976A (en) * | 1994-01-03 | 1996-02-20 | The Sherwin-Williams Company | Anhydride-functional polymers comprising ene reaction products of unsaturated anhydrides and polyolefins |
CA2140053C (en) * | 1994-02-09 | 2000-04-04 | Joel S. Rosenblatt | Collagen-based injectable drug delivery system and its use |
US6228383B1 (en) * | 1994-03-03 | 2001-05-08 | Gs Development Ab | Use of fatty acid esters as bioadhesive substances |
RU2118176C1 (en) * | 1996-09-27 | 1998-08-27 | Истранов Леонид Прокофьевич | Method of collagen plates preparing |
WO1998016165A1 (en) * | 1996-10-16 | 1998-04-23 | Fusion Medical Technologies, Inc. | Films having improved characteristics and methods for their preparation and use |
US5800832A (en) * | 1996-10-18 | 1998-09-01 | Virotex Corporation | Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces |
US20020025921A1 (en) | 1999-07-26 | 2002-02-28 | Petito George D. | Composition and method for growing, protecting, and healing tissues and cells |
AUPP437698A0 (en) * | 1998-06-30 | 1998-07-23 | Baumgart, Karl | Methods for treatment of coronary, carotid and other vascular disease |
US6132785A (en) * | 1998-10-29 | 2000-10-17 | J. R. Simplot Company | Process for preparing batter coated french fried potato strips |
WO2001024839A1 (en) * | 1999-10-01 | 2001-04-12 | Acrymed | Silver-containing compositions, devices and methods for making |
-
2005
- 2005-06-15 JP JP2007533836A patent/JP5047797B2/en active Active
- 2005-06-15 WO PCT/CA2005/000925 patent/WO2006034568A1/en active Application Filing
- 2005-06-15 ES ES05758716.4T patent/ES2581558T3/en active Active
- 2005-06-15 EP EP05758716.4A patent/EP1793872B1/en active Active
- 2005-06-15 US US11/152,367 patent/US8361501B2/en active Active
- 2005-06-15 US US11/664,184 patent/US20110097402A1/en not_active Abandoned
- 2005-06-15 AU AU2005289311A patent/AU2005289311B2/en active Active
- 2005-06-15 CA CA2580357A patent/CA2580357C/en active Active
- 2005-06-15 DK DK05758716.4T patent/DK1793872T3/en active
- 2005-06-15 UA UAA200703465A patent/UA88321C2/en unknown
- 2005-06-15 EA EA200900997A patent/EA016776B9/en not_active IP Right Cessation
- 2005-06-15 EA EA200700589A patent/EA012609B1/en unknown
-
2007
- 2007-03-29 NO NO20071668A patent/NO20071668L/en not_active Application Discontinuation
-
2011
- 2011-06-22 US US13/166,433 patent/US8354123B2/en active Active
-
2013
- 2013-01-25 US US13/750,872 patent/US8628800B2/en active Active
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3491760A (en) * | 1965-07-09 | 1970-01-27 | Braun Intern Gmbh B | Wound coverings |
US4703108A (en) * | 1984-03-27 | 1987-10-27 | University Of Medicine & Dentistry Of New Jersey | Biodegradable matrix and methods for producing same |
US5550187A (en) * | 1988-11-21 | 1996-08-27 | Collagen Corporation | Method of preparing crosslinked biomaterial compositions for use in tissue augmentation |
US5744545A (en) * | 1988-11-21 | 1998-04-28 | Collagen Corporation | Biocompatible adhesive compositions |
US5399361A (en) * | 1992-05-01 | 1995-03-21 | Amgen Inc. | Collagen-containing sponges as drug delivery compositions for proteins |
US20020131933A1 (en) * | 1996-01-16 | 2002-09-19 | Yves Delmotte | Biopolymer membrane and methods for its preparation |
US6132765A (en) * | 1996-04-12 | 2000-10-17 | Uroteq Inc. | Drug delivery via therapeutic hydrogels |
US6228393B1 (en) * | 1996-04-12 | 2001-05-08 | Uroteq, Inc. | Drug delivery via therapeutic hydrogels |
US6475516B2 (en) * | 1996-04-12 | 2002-11-05 | Dicosmo Frank | Drug delivery via therapeutic hydrogels |
US20030039695A1 (en) * | 2001-08-10 | 2003-02-27 | Ed. Geistlich Soehne Ag Fuer Chemische Industrie | Collagen carrier of therapeutic genetic material, and method |
US20060068013A1 (en) * | 2004-09-30 | 2006-03-30 | Ditizio Valerio | Non-adhesive elastic gelatin matrices |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090022801A1 (en) * | 2006-01-31 | 2009-01-22 | David Vachon | Compositions and Methods for Promoting the Healing of Tissue of Multicellular Organisms |
US20100247544A1 (en) * | 2006-01-31 | 2010-09-30 | Dr. David John Vachon | Compositions and Methods for Promoting the Healing of Tissue of Multicellular Organisms |
US8795730B2 (en) | 2006-01-31 | 2014-08-05 | David John Vachon | Compositions and methods for promoting the healing of tissue of multicellular organisms |
US9970303B2 (en) | 2014-05-13 | 2018-05-15 | Entrotech, Inc. | Erosion protection sleeve |
EP3088010A1 (en) | 2015-04-28 | 2016-11-02 | DiCosmo, Frank | Bioactive collagen biomaterials and methods for making |
US11058749B2 (en) | 2015-04-28 | 2021-07-13 | Frank DiCosmo | Bioactive collagen biomaterials and methods for making |
CN110075346A (en) * | 2019-04-30 | 2019-08-02 | 苏州卫生职业技术学院 | A kind of high-adhesiveness aerogel dressing and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
US8361501B2 (en) | 2013-01-29 |
NO20071668L (en) | 2007-06-28 |
EP1793872B1 (en) | 2016-05-11 |
JP5047797B2 (en) | 2012-10-10 |
DK1793872T3 (en) | 2016-07-25 |
AU2005289311A1 (en) | 2006-04-06 |
AU2005289311B2 (en) | 2011-03-03 |
EA200900997A1 (en) | 2009-12-30 |
JP2008514316A (en) | 2008-05-08 |
EP1793872A4 (en) | 2011-08-03 |
US20110311629A1 (en) | 2011-12-22 |
EA200700589A1 (en) | 2007-10-26 |
EP1793872A1 (en) | 2007-06-13 |
EA016776B9 (en) | 2012-11-30 |
US8354123B2 (en) | 2013-01-15 |
EA012609B1 (en) | 2009-10-30 |
EA016776B1 (en) | 2012-07-30 |
US20060068013A1 (en) | 2006-03-30 |
UA88321C2 (en) | 2009-10-12 |
US20130137780A1 (en) | 2013-05-30 |
WO2006034568A1 (en) | 2006-04-06 |
CA2580357A1 (en) | 2006-04-06 |
CA2580357C (en) | 2014-01-28 |
ES2581558T3 (en) | 2016-09-06 |
US8628800B2 (en) | 2014-01-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8628800B2 (en) | Non-adhesive elastic gelatin matrices | |
Puertas-Bartolomé et al. | Bioadhesive functional hydrogels: Controlled release of catechol species with antioxidant and antiinflammatory behavior | |
Choi et al. | Study on gelatin-containing artificial skin: I. Preparation and characteristics of novel gelatin-alginate sponge | |
KR101103423B1 (en) | In situ forming hydrogel for tissue adhesives and biomedical use thereof | |
US8029774B2 (en) | Wound healing polymeric networks | |
ES2416458T3 (en) | Materials for bandages | |
Luo et al. | Thermogelling chitosan-based polymers for the treatment of oral mucosa ulcers | |
WO2022143217A1 (en) | Medical device, and hydrogel, preparation method therefor, and application thereof | |
KR101820306B1 (en) | Gallic Acid-Chitosan Complexes and Composition for Wound Healing Comprising Them | |
WO2020134757A1 (en) | Medical sealing glue capable of promoting wound healing and preparation method therefor | |
Huang et al. | Preparation of novel stable microbicidal hydrogel films as potential wound dressing | |
Fan et al. | Flexible dual-functionalized hyaluronic acid hydrogel adhesives formed in situ for rapid hemostasis | |
Boles et al. | Characterization of trimethyl chitosan/polyethylene glycol derivatized chitosan blend as an injectable and degradable antimicrobial delivery system | |
Valipour et al. | Preparation and characterization of wound healing hydrogel based on fish skin collagen and chitosan cross-linked by dialdehyde starch | |
Özkahraman et al. | Synthesis of chitosan-based hydrogels as a novel drug release device for wound healing | |
CN114425105B (en) | Preparation method and application of antibacterial, hemostatic, repair-promoting and anti-adhesion combined multifunctional material | |
Baranes‐Zeevi et al. | Novel drug‐eluting soy‐protein structures for wound healing applications | |
RU2582220C1 (en) | Wound dressing based on chitosan | |
Olami et al. | Novel soy protein blend scaffolds loaded with antibiotics: Drug release profile—bacterial inhibition effects | |
Islam et al. | Polymer Matrixes Used in Wound Healing Applications | |
Evranos | The Synthesis of Ph-responsıve Polymeric Film wıth an Enhanced Mechanical Properties for Wound Dress Applications | |
WO2017205740A1 (en) | Process for preparing tissue regeneration matrix | |
Bibire et al. | Biopolymers for Surgical Applications. Coatings 2022, 12, 211 | |
Parker | Design and Preliminary Investigation of Crosslinked Chitosan Sponges for Tailorable Drug Delivery and Infection Control | |
TW201519916A (en) | A hydrogel material and method of preparing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: COVALON TECHNOLOGIES INC., CANADA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:DITIZIO, VALERIO;DICOSMO, FRANK;XIAO, YUEHUA;REEL/FRAME:021363/0512 Effective date: 20050729 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |